{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T02:56:41Z","timestamp":1792378601582,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd000031.pub5","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000}}],"reference-count":560,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd000031.pub6","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T07:11:11Z","timestamp":1684912271000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Antidepressants for smoking cessation"],"prefix":"10.1002","volume":"2023","author":[{"given":"Anisa","family":"Hajizadeh","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences; University of Oxford; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Howes","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences; University of Oxford; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Theodoulou","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences; University of Oxford; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Klemperer","sequence":"additional","affiliation":[{"name":"Departments of Psychological Sciences & Psychiatry; University of Vermont; Burlington VT USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Hartmann-Boyce","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences; University of Oxford; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Livingstone-Banks","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences; University of Oxford; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Lindson","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences; University of Oxford; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,5,24]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD000031.pub6-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4103\/ecdt.ecdt_15_21","article-title":"Efficacy of nicotine-replacement therapy, bupropion, and a combination of both for treating nicotine addiction: a randomized clinical trial","volume":"71","author":"Abdelghany","year":"2022","journal-title":"Egyptian Journal of Chest Diseases and Tuberculosis"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0002|cit2","unstructured":"Efficacy of nicotine replacement therapy, bupropion and both for treating nicotine addiction trialsearch.who.int\/Trial2.aspx?TrialID=PACTR201904758098529"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1001\/jama.288.4.468","article-title":"Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial","volume":"288","author":"Ahluwalia","year":"2002","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1207\/s15327558ijbm1204_7","article-title":"Self-efficacy and motivation to quit during participation in a smoking cessation program","volume":"12","author":"Boardman","year":"2005","journal-title":"International Journal of Behavioral Medicine"},{"issue":"6","key":"10.1002\/14651858.CD000031.pub6-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1080\/14622200500330118","article-title":"The influence of depressive symptoms on smoking cessation among African Americans in a randomized trial of bupropion","volume":"7","author":"Catley","year":"2005","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/1462220031000118540","article-title":"Successful recruitment of minorities into clinical trials: the Kick It at Swope project","volume":"5","author":"Harris","year":"2003","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ypmed.2003.12.008","article-title":"Predictors of smoking cessation among African-Americans enrolled in a randomized controlled trial of bupropion","volume":"38","author":"Harris","year":"2004","journal-title":"Preventive Medicine"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1046\/j.1360-0443.2003.00443.x","article-title":"Does menthol attenuate the effect of bupropion among African American smokers?","volume":"98","author":"Okuyemi","year":"2003","journal-title":"Addiction"},{"issue":"9","key":"10.1002\/14651858.CD000031.pub6-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s11606-008-0656-3","article-title":"The impact of perceived treatment assignment on smoking cessation outcomes among African-American smokers","volume":"23","author":"Thomas","year":"2008","journal-title":"Journal of General Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD000031.pub6-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/clpt.2014.88","article-title":"Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokers","volume":"96","author":"Zhu","year":"2014","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"10037","key":"10.1002\/14651858.CD000031.pub6-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/S0140-6736(16)30272-0","article-title":"Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial","volume":"387","author":"Anthenelli","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD000031.pub6-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s11606-019-04858-2","article-title":"Predictors of neuropsychiatric adverse events with smoking cessation medications in the randomized controlled EAGLES Trial","volume":"34","author":"Anthenelli","year":"2019","journal-title":"Journal of General Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD000031.pub6-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/da.22982","article-title":"Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: subgroup analysis of the randomized, active- and placebo-controlled EAGLES trial","volume":"37","author":"Ayers","year":"2020","journal-title":"Depression and Anxiety"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2147\/CEOR.S153897","article-title":"A cost-effectiveness analysis of varenicline for smoking cessation using data from the EAGLES trial","volume":"10","author":"Baker","year":"2018","journal-title":"ClinicoEconomics and Outcomes Research"},{"issue":"10","key":"10.1002\/14651858.CD000031.pub6-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/add.15440","article-title":"Estimation of risk of neuropsychiatric adverse events from varenicline, bupropion and nicotine patch versus placebo: secondary analysis of results from the EAGLES trial using Bayes factors","volume":"116","author":"Beard","year":"2021","journal-title":"Addiction"},{"issue":"5","key":"10.1002\/14651858.CD000031.pub6-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1001\/jamainternmed.2018.0397","article-title":"Cardiovascular safety of varenicline, bupropion, and nicotine patch in smokers: a randomized clinical trial","volume":"178","author":"Benowitz","year":"2018","journal-title":"JAMA Internal Medicine"},{"issue":"10","key":"10.1002\/14651858.CD000031.pub6-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1093\/ntr\/ntab056","article-title":"Psychiatric co-morbidity and multi-morbidity in the EAGLES trial: descriptive correlates and associations with neuropsychiatric adverse events, treatment adherence, and smoking cessation","volume":"23","author":"Correa","year":"2021","journal-title":"Nicotine & Tobacco Research"},{"issue":"7","key":"10.1002\/14651858.CD000031.pub6-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.mayocp.2020.10.046","article-title":"Frequently reported adverse events with smoking cessation medications: post hoc analysis of a randomized trial","volume":"96","author":"Ebbert","year":"2021","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0019|cit19","unstructured":"A phase 4, randomized, double-blind, active and placebo -controlled, multicenter study evaluating the neuropsychiatric safety and efficacy of 12 weeks varenicline tartrate 1mg bid and bupropion hydrochloride 150mg bid for smoking cessation in subjects with and without a history of psychiatric disorders clinicaltrialsregister.eu\/ctr-search\/search?query=2010-022914-15"},{"issue":"2","key":"10.1002\/14651858.CD000031.pub6-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/JCP.0000000000001015","article-title":"Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with psychotic, anxiety, and mood disorders in the EAGLES Trial","volume":"39","author":"Evins","year":"2019","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD000031.pub6-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1176\/appi.ps.202000032","article-title":"Efficacy and safety of pharmacotherapeutic smoking cessation aids in schizophrenia spectrum disorders: subgroup analysis of EAGLES","volume":"72","author":"Evins","year":"2021","journal-title":"Psychiatric Services"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jad.2019.06.008","article-title":"Safety and efficacy of first-line smoking cessation pharmacotherapies in bipolar disorders: subgroup analysis of a randomized clinical trial","volume":"256","author":"Heffner","year":"2019","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0023|cit23","unstructured":"Study evaluating the safety and efficacy of varenicline and bupropion for smoking cessation in subjects with and without a history of psychiatric disorders clinicaltrials.gov\/ct2\/show\/NCT01330030"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0024|cit24","unstructured":"Study to evaluate cardiac assessments following different treatments of smoking cessation medications in subjects with and without psychiatric disorders clinicaltrials.gov\/ct2\/show\/NCT01574703"},{"issue":"1","key":"10.1002\/14651858.CD000031.pub6-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"e2032053","DOI":"10.1001\/jamanetworkopen.2020.32053","article-title":"Assessment of racial differences in pharmacotherapy efficacy for smoking cessation: secondary analysis of the EAGLES randomized clinical trial","volume":"4","author":"Nollen","year":"2021","journal-title":"JAMA Network Open"},{"issue":"8","key":"10.1002\/14651858.CD000031.pub6-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/add.14208","article-title":"Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLES","volume":"113","author":"West","year":"2018","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0027|cit27","first-page":"S106","article-title":"A double-blind, active-and placebo-controlled evaluation of the neuropsychiatric safety and efficacy of varenicline and bupropion for smoking cessation in subjects with (pre-existing) psychiatric disorders: an objective blinded analysis","volume":"40","author":"Wilcox","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1360-0443.2004.00814.x","article-title":"Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial","volume":"99","author":"Aubin","year":"2004","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0029|cit29","unstructured":"Lebargy F Aubin HJ Lagrue G Bidaut-Mazel C Chemali-Hudry J Poulain L A placebo-controlled, double-blind study of Zyban LP: an effective and well-tolerated aid to smoking cessation - preliminary results (POS4-69) Society for Research on Nicotine and Tobacco 9th Annual Meeting; 2003 February 19-22; New Orleans (LA) 2003"},{"issue":"7655","key":"10.1002\/14651858.CD000031.pub6-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1136\/bmj.39545.852616.BE","article-title":"Nortriptyline plus nicotine replacement versus placebo plus nicotine replacement for smoking cessation: pragmatic randomised controlled trial","volume":"336","author":"Aveyard","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0031|cit31","unstructured":"Aveyard P Johnson C Murphy M Johnstone E Walton R Fillingham S A pragmatic randomised controlled trial to test the efficacy of nortriptyline plus nicotine replacement therapy (NRT) versus a placebo plus NRT in helping smokers to stop and testing the role of noradrenergic and dopaminergic genetic variants in smoking cessation [PI-TS-02] Society for Research on Nicotine and Tobacco 8th European Meeting; 2006 September 23-26; Kusadasi, Turkey 2006"},{"issue":"4","key":"10.1002\/14651858.CD000031.pub6-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1055\/s-2005-916219","article-title":"A pilot randomised, open, uncontrolled, clinical study of two dosages of St John's wort (Hypericum perforatum) herb extract (LI-160) as an aid to motivational\/behavioural support in smoking cessation","volume":"72","author":"Barnes","year":"2006","journal-title":"Planta Medica"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12971-017-0116-0","article-title":"A comparison of the efficacy of varenicline and bupropion and an evaluation of the effect of the medications in the context of the smoking cessation programme","volume":"15","author":"Benli","year":"2017","journal-title":"Tobacco Induced Diseases"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/0009-9236(95)90058-6","article-title":"A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers","volume":"58","author":"Berlin","year":"1995","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0376-8716(97)01338-0","article-title":"Effects of past history of major depression on smoking characteristics, monoamine oxidase-A and -B activities and withdrawal symptoms in dependent smokers","volume":"45","author":"Berlin","year":"1997","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1046\/j.1360-0443.2002.00258.x","article-title":"Lazabemide, a selective, reversible monoamine oxidase B inhibitor, as an aid to smoking cessation","volume":"97","author":"Berlin","year":"2002","journal-title":"Addiction"},{"issue":"1","key":"10.1002\/14651858.CD000031.pub6-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00213-012-2692-2","article-title":"A selective reversible monoamine oxidase B inhibitor in smoking cessation: effects on its own and in association with transdermal nicotine patch","volume":"223","author":"Berlin","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1046\/j.1360-0443.2003.00524.x","article-title":"A randomized controlled trial of oral selegiline plus nicotine skin patch compared with placebo plus nicotine skin patch for smoking cessation","volume":"98","author":"Biberman","year":"2003","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1046\/j.1360-0443.1999.94710076.x","article-title":"The effects of fluoxetine combined with nicotine inhalers in smoking cessation - a randomized trial","volume":"94","author":"Blondal","year":"1999","journal-title":"Addiction"},{"issue":"1","key":"10.1002\/14651858.CD000031.pub6-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/10550490802545182","article-title":"Regular exercise as a protective factor in relapse following smoking cessation treatment","volume":"18","author":"Abrantes","year":"2009","journal-title":"American Journal on Addictions"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1080\/14622200701416955","article-title":"Bupropion and cognitive-behavioral treatment for depression in smoking cessation","volume":"9","author":"Brown","year":"2007","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/14622200701382033","article-title":"Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation","volume":"9","author":"David","year":"2007","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1080\/14622200310001615295","article-title":"Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?","volume":"5","author":"David","year":"2003","journal-title":"Nicotine & Tobacco Research"},{"issue":"12","key":"10.1002\/14651858.CD000031.pub6-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1111\/add.12325","article-title":"Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion","volume":"108","author":"David","year":"2013","journal-title":"Addiction"},{"issue":"12","key":"10.1002\/14651858.CD000031.pub6-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1080\/14622200701705027","article-title":"Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials","volume":"9","author":"David","year":"2007","journal-title":"Nicotine & Tobacco Research"},{"issue":"1","key":"10.1002\/14651858.CD000031.pub6-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/tpj.2010.64","article-title":"Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation","volume":"12","author":"Leventhal","year":"2012","journal-title":"Pharmacogenomics Journal"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0047|cit47","doi-asserted-by":"crossref","unstructured":"Li Y Wileyto EP Heitjan DF Modeling smoking cessation data with alternating states and a cure fraction using frailty models Statistics in Medicine 2010 29 6 627 38","DOI":"10.1002\/sim.3825"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0048|cit48","doi-asserted-by":"crossref","unstructured":"Okun ML Levine MD Houck P Perkins KA Marcus MD Subjective sleep disturbance during a smoking cessation program: associations with relapse Addictive Behaviors 2011 36 8 861 4","DOI":"10.1016\/j.addbeh.2011.03.001"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0049|cit49","doi-asserted-by":"crossref","unstructured":"Strong DR Kahler CW Leventhal AM Abrantes AM Lloyd-Richardson E Niaura R Impact of bupropion and cognitive-behavioral treatment for depression on positive affect, negative affect, and urges to smoke during cessation treatment Nicotine & Tobacco Research 2009 11 10 1142 53","DOI":"10.1093\/ntr\/ntp111"},{"issue":"6","key":"10.1002\/14651858.CD000031.pub6-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/archpsyc.65.6.683","article-title":"Molecular genetics of successful smoking cessation: convergent genome-wide association study results","volume":"65","author":"Uhl","year":"2008","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000031.pub6-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/ntr\/ntt134","article-title":"Efficacy of sequential use of fluoxetine for smoking cessation in elevated depressive symptom smokers","volume":"16","author":"Brown","year":"2014","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0052|cit52","unstructured":"Brown RA Strong DR Abrantes AM Miller IW Kahler CW Niaura R Efficacy of sequential use of fluoxetine for smoking cessation in elevated depressive symptom smokers Society for Research on Nicotine & Tobacco 17th Annual Meeting; 2011 February 16-19; Toronto, Canada 2011 28S"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0053|cit53","unstructured":"Brown RA Strong DR Miller IW Kahler CW Niaura R Price LH Efficacy of sequential vs. concurrent use of fluoxetine in smoking cessation for elevated depressive symptom smokers (SYM8D) Society for Research on Nicotine and Tobacco 13th Annual Meeting; 2007 February 21-24, Austin (TX) 2007"},{"issue":"1","key":"10.1002\/14651858.CD000031.pub6-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/ADT.0000000000000042","article-title":"Effects of depression history and sex on the efficacy of sequential versus standard fluoxetine for smoking cessation in elevated depressive symptom smokers","volume":"14","author":"Minami","year":"2015","journal-title":"Addictive Disorders & Their Treatment"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0055|cit55","unstructured":"Cinciripini PM Tsoh JY Friedman K Wetter D Cinciripini LG Skaar KL A placebo controlled evaluation of venlafaxine for smoking cessation: preliminary findings [Abstract A18] Society for Research on Nicotine and Tobacco Annual Meeting; 1998 Mar 27-29; New Orleans (LA) 1998"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1037\/1064-1297.13.4.282","article-title":"Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation","volume":"13","author":"Cinciripini","year":"2005","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0057|cit57","unstructured":"Cinciripini PM Wetter D Minna J Tsoh JY Gritz ER Baile WF The effects of brief counseling, transdermal nicotine replacement and antidepressant therapy on smoking cessation among smokers carrying the DRD2 A1 allele (PA3A) Society for Research on Nicotine and Tobacco Fifth Annual Meeting; 1999 March 5-7; San Diego (CA) 1999"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/14622200410001676396","article-title":"The effects of the DRD2 polymorphism on smoking cessation and negative affect: Evidence for a pharmacogenetic effect on mood","volume":"6","author":"Cinciripini","year":"2004","journal-title":"Nicotine & Tobacco Research"},{"issue":"11","key":"10.1002\/14651858.CD000031.pub6-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s00213-017-4580-2","article-title":"Benefits of varenicline vs. bupropion for smoking cessation: a Bayesian analysis of the interaction of reward sensitivity and treatment","volume":"234","author":"Cinciripini","year":"2017","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD000031.pub6-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/jamapsychiatry.2013.678","article-title":"Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal","volume":"70","author":"Cinciripini","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijpsycho.2017.12.001","article-title":"Pharmacological intervention and abstinence in smokers undergoing cessation treatment: a psychophysiological study","volume":"123","author":"Cui","year":"2018","journal-title":"International Journal of Psychophysiology"},{"issue":"2","key":"10.1002\/14651858.CD000031.pub6-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/ntr\/ntx264","article-title":"Brain responses to cigarette-related and emotional images in smokers during smoking cessation: no effect of varenicline or bupropion on the late positive potential","volume":"21","author":"Versace","year":"2017","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1111\/add.14250","article-title":"An RCT with the combination of varenicline and bupropion for smoking cessation: clinical implications for front line use","volume":"113","author":"Cinciripini","year":"2018","journal-title":"Addiction"},{"issue":"7","key":"10.1002\/14651858.CD000031.pub6-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/ntr\/nts245","article-title":"The DRD4 Exon III VNTR, bupropion, and associations with prospective abstinence","volume":"15","author":"Bergen","year":"2013","journal-title":"Nicotine & Tobacco Research"},{"issue":"1","key":"10.1002\/14651858.CD000031.pub6-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.biopsych.2006.04.030","article-title":"Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence","volume":"61","author":"Berrettini","year":"2007","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/14622200310001656830","article-title":"Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling","volume":"6","author":"Collins","year":"2004","journal-title":"Nicotine & Tobacco Research"},{"issue":"18","key":"10.1002\/14651858.CD000031.pub6-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1093\/hmg\/ddn181","article-title":"Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation","volume":"17","author":"Conti","year":"2008","journal-title":"Human Molecular Genetics"},{"issue":"12","key":"10.1002\/14651858.CD000031.pub6-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1111\/add.12325","article-title":"Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion","volume":"108","author":"David","year":"2013","journal-title":"Addiction"},{"issue":"12","key":"10.1002\/14651858.CD000031.pub6-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1080\/14622200701705027","article-title":"Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials","volume":"9","author":"David","year":"2007","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0070|cit70","unstructured":"Gold AB Wileyto EP Jepson C Lori A Cubells JF Lerman C Galanin receptor 1 (GALR1) SNP is associated with craving and smoking relapse Neuropsychopharmacology 2011 36 S378"},{"issue":"7","key":"10.1002\/14651858.CD000031.pub6-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1038\/npp.2012.13","article-title":"Pharmacogenetic association of the galanin receptor (GALR1) SNP rs2717162 with smoking cessation","volume":"37","author":"Gold","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1002\/14651858.CD000031.pub6-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1038\/oby.2006.215","article-title":"No evidence for a major role of polymorphisms during bupropion treatment","volume":"14","author":"Hu","year":"2006","journal-title":"Obesity"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0073|cit73","doi-asserted-by":"crossref","unstructured":"Javitz HS Swan GE Lerman C The dynamics of the urge-to-smoke following smoking cessation via pharmacotherapy Addiction 2011 106 10 1835 45","DOI":"10.1111\/j.1360-0443.2011.03495.x"},{"issue":"6","key":"10.1002\/14651858.CD000031.pub6-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.biopsych.2006.10.005","article-title":"CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial","volume":"62","author":"Lee","year":"2007","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD000031.pub6-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/tpj.2011.30","article-title":"Gender-stratified gene and gene-treatment interactions in smoking cessation","volume":"12","author":"Lee","year":"2012","journal-title":"Pharmacogenomics Journal"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.npp.1300861","article-title":"Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials","volume":"31","author":"Lerman","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1037\/0893-164X.18.4.362","article-title":"Effect of bupropion on depression symptoms in a smoking cessation clinical trial","volume":"18","author":"Lerman","year":"2004","journal-title":"Psychology of Addictive Behaviors"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0376-8716(02)00067-4","article-title":"Mediating mechanisms for the impact of bupropion in smoking cessation treatment","volume":"67","author":"Lerman","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1037\/0278-6133.22.5.541","article-title":"Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial","volume":"22","author":"Lerman","year":"2003","journal-title":"Health Psychology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00008571-200211000-00007","article-title":"Pharmacogenetic investigation of smoking cessation treatment","volume":"12","author":"Lerman","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/clpt.2008.57","article-title":"Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion","volume":"84","author":"Patterson","year":"2008","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD000031.pub6-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jsat.2007.04.004","article-title":"Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation","volume":"34","author":"Schnoll","year":"2008","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"6","key":"10.1002\/14651858.CD000031.pub6-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/archpsyc.65.6.683","article-title":"Molecular genetics of successful smoking cessation: convergent genome-wide association study results","volume":"65","author":"Uhl","year":"2008","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/14622200500055673","article-title":"Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropion","volume":"7","author":"Wileyto","year":"2005","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/1462220042000202463","article-title":"Do small lapses predict relapse to smoking behavior under bupropion treatment?","volume":"6","author":"Wileyto","year":"2004","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0086|cit86","doi-asserted-by":"crossref","unstructured":"Berlin I Chen H Covey LS Depressive mood, suicide ideation and anxiety in smokers who do and smokers who do not manage to stop smoking after a target quit date Addiction 2010 105 12 2209 16","DOI":"10.1111\/j.1360-0443.2010.03109.x"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1176\/appi.ajp.159.10.1731","article-title":"A randomized trial of sertraline as a cessation aid for smokers with a history of major depression","volume":"159","author":"Covey","year":"2002","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0088|cit88","unstructured":"Covey LS Glassman AH Stetner F Rivelli S A trial of sertraline for smokers with past major depression Society for Research on Nicotine and Tobacco Meeting. Arlington, VA (www.srnt.org\/events\/abstracts99\/index.htm) 2000"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0089|cit89","unstructured":"Maintenance treatment for abstinent smokers clinicaltrials.gov\/ct2\/show\/NCT00063323"},{"issue":"2","key":"10.1002\/14651858.CD000031.pub6-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/1359105311414953","article-title":"Assessment of depression among African American light smokers","volume":"17","author":"Berg","year":"2012","journal-title":"Journal of Health Psychology"},{"issue":"4","key":"10.1002\/14651858.CD000031.pub6-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1158\/1055-9965.EPI-11-0098","article-title":"Perceived treatment assignment and smoking cessation in a clinical trial of bupropion","volume":"20","author":"Buchanan","year":"2011","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"2","key":"10.1002\/14651858.CD000031.pub6-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/ntr\/nts143","article-title":"Perceived treatment assignment and smoking cessation in a clinical trial of bupropion versus placebo","volume":"15","author":"Buchanan","year":"2013","journal-title":"Nicotine & Tobacco Research"},{"issue":"6","key":"10.1002\/14651858.CD000031.pub6-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1111\/add.15742","article-title":"Does sex alter the relationship between CYP2B6 variation, hydroxybupropion concentration and bupropion-aided smoking cessation in African Americans? A moderated mediation analysis","volume":"117","author":"Chenoweth","year":"2022","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0094|cit94","doi-asserted-by":"crossref","unstructured":"Cox LS Faseru B Mayo MS Krebill R Snow TS Bronars CA Design, baseline characteristics, and retention of African American light smokers into a randomized trial involving biological data Trials 2011 12 22","DOI":"10.1186\/1745-6215-12-22"},{"issue":"4","key":"10.1002\/14651858.CD000031.pub6-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/jnci\/djr513","article-title":"Bupropion for smoking cessation in African American light smokers: a randomized controlled trial","volume":"104","author":"Cox","year":"2012","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0096|cit96","doi-asserted-by":"crossref","unstructured":"Faseru B Choi WS Krebill R Mayo MS Nollen NL Okuyemi KS Factors associated with smoking menthol cigarettes among treatment-seeking African American light smokers Addictive Behaviors 2011 36 12 1321 4","DOI":"10.1016\/j.addbeh.2011.07.015"},{"issue":"3","key":"10.1002\/14651858.CD000031.pub6-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.addbeh.2012.11.010","article-title":"Predictors of cessation in African American light smokers enrolled in a bupropion clinical trial","volume":"38","author":"Faseru","year":"2013","journal-title":"Addictive Behaviors"},{"issue":"3","key":"10.1002\/14651858.CD000031.pub6-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s12160-013-9510-x","article-title":"Factors associated with discontinuation of bupropion and counseling among African American light smokers in a randomized clinical trial","volume":"46","author":"Nollen","year":"2013","journal-title":"Annals of Behavioral Medicine"},{"issue":"6","key":"10.1002\/14651858.CD000031.pub6-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/clpt.2012.186","article-title":"CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropion","volume":"92","author":"Zhu","year":"2012","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD000031.pub6-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/clpt.2014.88","article-title":"Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokers","volume":"96","author":"Zhu","year":"2014","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"5 Suppl","key":"10.1002\/14651858.CD000031.pub6-BIB0101|cit101","first-page":"A354","article-title":"Smoking cessation: a randomized double-blind study comparing nortriptyline to placebo [abstract]","volume":"163","author":"da Costa","year":"2001","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1378\/chest.122.2.403","article-title":"Stopping smoking: a prospective, randomized, double-blind study comparing nortriptyline to placebo","volume":"122","author":"da Costa","year":"2002","journal-title":"Chest"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14622200310001656867","article-title":"A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees","volume":"6","author":"Dalsgar\u00f0","year":"2004","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0104|cit104","unstructured":"Dalsgar\u00f0 OJ Vestbo J A multicenter, randomised, double-blind, placebo-controlled 6 month trial to evaluate efficacy and tolerability of bupropion hydrochloride sustained release (SR) tablets as treatment for nicotine dependency in healthcare workers and as an aid to smoking cessation (ZYB30009). Poster and oral presentation European Congress on Tobacco or Health; 2002 June 20-22; Warsaw, Poland 2002"},{"issue":"2","key":"10.1002\/14651858.CD000031.pub6-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/jama.2013.283185","article-title":"Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial","volume":"311","author":"Ebbert","year":"2014","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jsat.2014.11.010","article-title":"Depressive symptoms among patients receiving varenicline and bupropion for smoking cessation","volume":"52","author":"Hong","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"5","key":"10.1002\/14651858.CD000031.pub6-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jacc.2012.11.017","article-title":"Smoking cessation after acute myocardial infarction","volume":"61","author":"Benowitz","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD000031.pub6-BIB0108|cit108","first-page":"S344","article-title":"Bupropion for smoking cessation in patients hospitalized with acute myocardial infarction: a randomized, placebo-controlled trial","volume":"27","author":"Eisenberg","year":"2011","journal-title":"Canadian Journal of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD000031.pub6-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jacc.2012.08.1030","article-title":"Bupropion for smoking cessation in patients hospitalized with acute myocardial infarction: a randomized, placebo-controlled trial","volume":"61","author":"Eisenberg","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0110|cit110","first-page":"P090","article-title":"The effect of bupropion on symptoms of depression among patients attempting to quit smoking post-myocardial infarction: the ZESCA trial","volume":"125 Suppl 10","author":"Filion","year":"2012","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0111|cit111","doi-asserted-by":"crossref","unstructured":"Grandi S Filion K Gervais A Joseph L O'Loughlin J Paradis G The effect of adherence to treatment on smoking abstinence in patients post-acute myocardial infarction 61st Annual Scientific Session of the American College of Cardiology and i2 Summit: Innovation in Intervention, ACC.12; 2012 March 24-27; Chicago (IL) 2012 E1749","DOI":"10.1016\/S0735-1097(12)61750-1"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ahj.2015.12.003","article-title":"Cessation treatment adherence and smoking abstinence in patients after acute myocardial infarction","volume":"173","author":"Grandi","year":"2016","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0113|cit113","doi-asserted-by":"crossref","unstructured":"Grandi SM Filion KB Gervais A Joseph L O'Loughlin J Paradis G The effect of smoking cessation on weight at 12 months in patients post-myocardial infarction [abstract] Circulation 2012 P090","DOI":"10.1161\/circ.125.suppl_10.AP323"},{"issue":"2","key":"10.1002\/14651858.CD000031.pub6-BIB0114|cit114","first-page":"123","article-title":"The effect of treatment adherence on smoking abstinence in patients post-acute myocardial infarction","volume":"19","author":"Grandi","year":"2012","journal-title":"Journal of Population Therapeutics and Clinical Pharmacology"},{"issue":"7","key":"10.1002\/14651858.CD000031.pub6-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.amjmed.2014.02.032","article-title":"Weight change in patients attempting to quit smoking post-myocardial infarction","volume":"127","author":"Grandi","year":"2014","journal-title":"American Journal of Medicine"},{"issue":"10 Suppl 1","key":"10.1002\/14651858.CD000031.pub6-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"S257","DOI":"10.1016\/j.cjca.2013.07.422","article-title":"Baseline predictors of relapse to smoking at 12 months in patients post-myocardial infarction","volume":"29","author":"Grandi","year":"2013","journal-title":"Canadian Journal of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD000031.pub6-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.amjcard.2013.11.024","article-title":"Utilization of evidence-based therapy for acute coronary syndrome in high-income and low\/middle-income countries","volume":"113","author":"Shimony","year":"2014","journal-title":"American Journal of Cardiology"},{"issue":"13 Suppl 1","key":"10.1002\/14651858.CD000031.pub6-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"E364","DOI":"10.1016\/S0735-1097(12)60365-9","article-title":"Use of medical therapy in patients 12 months post-acute myocardial infarction","volume":"59","author":"Windle","year":"2012","journal-title":"Journal of the American College of Cardiology"},{"issue":"10 Suppl 1","key":"10.1002\/14651858.CD000031.pub6-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"S290","DOI":"10.1016\/j.cjca.2013.07.485","article-title":"Bupropion, smoking cessation, and health-related quality of life following an acute myocardial infarction","volume":"29","author":"Zhang","year":"2013","journal-title":"Canadian Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD000031.pub6-BIB0120|cit120","first-page":"e346","article-title":"Bupropion, smoking cessation, and health-related quality of life following an acute myocardial infarction","volume":"21","author":"Zhang","year":"2014","journal-title":"Journal of Population Therapeutics and Clinical Pharmacology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0121|cit121","unstructured":"Elsasser GN Guck TP Destache CJ Daher PM Frey DR Jones J Sustained release bupropion in the treatment of nicotine addiction among teenage smokers (RP-32) Rapid Communication Poster Abstracts. Society for Research on Nicotine and Tobacco 8th Annual Meeting; 2002 February 20-23; Savannah (GA) 2002"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4088\/JCP.v65n0304","article-title":"Two-year follow-up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction","volume":"65","author":"Evins","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/14622200110073920","article-title":"A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia","volume":"3","author":"Evins","year":"2001","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0124|cit124","first-page":"806","article-title":"Smoking cessation in schizophrenia: a double blind placebo controlled trial of bupropion SR added to cognitive behavioral therapy","volume":"55","author":"Evins","year":"2004","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.jcp.0000162802.54076.18","article-title":"A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia","volume":"25","author":"Evins","year":"2005","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.4088\/JCP.v66n0915","article-title":"Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia","volume":"66","author":"Evins","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0127|cit127","unstructured":"Evins AE Cather C Culhane M Birnbaum AS Horowitz J Hsieh E A placebo-controlled study of bupropion SR added to high dose nicotine replacement therapy for smoking cessation or reduction in schizophrenia (POS2-104) Society for Research on Nicotine and Tobacco 12th Annual Meeting; 2006 February 15-18; Orlando (FL) 2006"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/01.jcp.0b013e3180ca86fa","article-title":"A 12-week double-blind, placebo-controlled study of bupropion SR added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia","volume":"27","author":"Evins","year":"2007","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0129|cit129","unstructured":"Safety and effectiveness of sustained release bupropion in treating individuals with schizophrenia who smoke clinicaltrials.gov\/ct2\/show\/NCT00307203"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000031.pub6-BIB0130|cit130","first-page":"S91","article-title":"A double blind placebo controlled trial of bupropion added to nicotine patch and cognitive behavioral therapy in smokers with current or past unipolar depressive disorder","volume":"30","author":"Evins","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/JCP.0b013e31818ad7d6","article-title":"A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders","volume":"28","author":"Evins","year":"2008","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1-3","key":"10.1002\/14651858.CD000031.pub6-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.schres.2013.02.015","article-title":"Antismoking and potential antipsychotic effects of varenicline in subjects with schizophrenia or schizoaffective disorder: a double-blind placebo and bupropion-controlled study","volume":"146","author":"Fatemi","year":"2013","journal-title":"Schizophrenia Research"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD000031.pub6-BIB0133|cit133","first-page":"I","article-title":"Enhancement of smoking cessation using the antidepressant bupropion hydrochloride","volume":"86","author":"Ferry","year":"1992","journal-title":"Circulation"},{"issue":"4","key":"10.1002\/14651858.CD000031.pub6-BIB0134|cit134","first-page":"249","article-title":"Efficacy of bupropion for smoking cessation in non depressed smokers [Abstract]","volume":"13","author":"Ferry","year":"1994","journal-title":"Journal of Addictive Diseases"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2466\/pr0.102.3.687-694","article-title":"An evaluation of the Italian version of the Fagerstrom Test for Nicotine Dependence","volume":"102","author":"Ferketich","year":"2008","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1001\/archinte.167.16.1791","article-title":"A double-blind, placebo-controlled, randomized trial of bupropion for smoking cessation in primary care","volume":"167","author":"Fossati","year":"2007","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0137|cit137","doi-asserted-by":"crossref","unstructured":"Gariti P Lynch K Alterman A Kampman K Xie H Varillo K Comparing smoking treatment programs for lighter smokers with and without a history of heavier smoking Journal of Substance Abuse Treatment 2009 37 3 247 55","DOI":"10.1016\/j.jsat.2009.01.006"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0006-3223(02)01339-2","article-title":"A placebo controlled trial of bupropion for smoking cessation in schizophrenia","volume":"52","author":"George","year":"2002","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000031.pub6-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0006-3223(02)01454-3","article-title":"A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation","volume":"53","author":"George","year":"2003","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0140|cit140","unstructured":"Lara XD Vessicchio JC Termine A Kosten TR O'Malley SS George TP Selegiline versus placebo for smoking cessation in nicotine dependent refractory smokers (PO2 02) Society for Research on Nicotine and Tobacco 7th Annual Meeting; 2001 March 23; Seattle (WA) 2001 53"},{"issue":"11","key":"10.1002\/14651858.CD000031.pub6-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.biopsych.2007.11.002","article-title":"A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia","volume":"63","author":"George","year":"2008","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0142|cit142","unstructured":"George TP Vessicchio JC Weinberger AH Sacco KA Sustained-release bupropion combined with transdermal nicotine patch for smoking cessation in schizophrenia (SYM11C) Society for Research on Nicotine and Tobacco 13th Annual Meeting; 2007 February 21-24; Austin (TX) 2007"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0143|cit143","doi-asserted-by":"crossref","unstructured":"Moss TG Sacco KA Allen TM Weinberger AH Vessicchio JC George TP Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia Drug and Alcohol Dependence 2009 104 1-2 94 9","DOI":"10.1016\/j.drugalcdep.2009.04.005"},{"issue":"6","key":"10.1002\/14651858.CD000031.pub6-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1037\/pha0000278","article-title":"Smoking cessation symptoms across 67 days compared with randomized controls-moderation by nicotine replacement therapy, bupropion, and negative-affect traits","volume":"27","author":"Gilbert","year":"2019","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0145|cit145","unstructured":"Gonzales D Nides M Ferry LH Segall N Herrero L Modell J Retreatment with bupropion SR: results from 12-month follow-up (RP-83) Rapid Communication Poster Abstracts. Society for Research on Nicotine and Tobacco 8th Annual Meeting; 2002 February 20-23; Savannah (GA) 2002"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1067\/mcp.2001.115750","article-title":"Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: a randomized placebo-controlled study","volume":"69","author":"Gonzales","year":"2001","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.296.1.47","article-title":"Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial","volume":"296","author":"Gonzales","year":"2006","journal-title":"JAMA"},{"issue":"10","key":"10.1002\/14651858.CD000031.pub6-BIB0148|cit148","first-page":"848","article-title":"Varenicline effective for smoking cessation","volume":"55","author":"Gonzales","year":"2006","journal-title":"Journal of Family Practice"},{"issue":"2","key":"10.1002\/14651858.CD000031.pub6-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/eurpub\/ckq137","article-title":"Changes in health-related quality of life with smoking cessation treatment","volume":"22","author":"Hays","year":"2012","journal-title":"European Journal of Public Health"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0150|cit150","doi-asserted-by":"crossref","unstructured":"Hays JT Leischow SJ Lawrence D Lee TC Adherence to treatment for tobacco dependence: association with smoking abstinence and predictors of adherence Nicotine & Tobacco Research 2010 12 6 574 81","DOI":"10.1093\/ntr\/ntq047"},{"issue":"4","key":"10.1002\/14651858.CD000031.pub6-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/JOM.0b013e3180459ff2","article-title":"An employer-based cost-benefit analysis of a novel pharmacotherapy agent for smoking cessation","volume":"49","author":"Jackson","year":"2007","journal-title":"Journal of Occupational & Environmental Medicine"},{"issue":"3","key":"10.1002\/14651858.CD000031.pub6-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/npp.2011.232","article-title":"Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials","volume":"37","author":"King","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0153|cit153","doi-asserted-by":"crossref","unstructured":"Prignot J Care for adherence to treatment for tobacco dependence Breathe 2011 7 3 291","DOI":"10.1183\/20734735.003711"},{"issue":"3","key":"10.1002\/14651858.CD000031.pub6-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00213-007-1041-3","article-title":"Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt","volume":"197","author":"West","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"411","DOI":"10.5603\/ARM.28222","article-title":"Effect of treatment for nicotine dependence in patients with COPD","volume":"71","author":"G\u00f3recka","year":"2003","journal-title":"Pneumonologia i Alergologia Polska"},{"issue":"5","key":"10.1002\/14651858.CD000031.pub6-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.alcohol.2007.03.011","article-title":"Bupropion and nicotine patch as smoking cessation aids in alcoholics","volume":"41","author":"Grant","year":"2007","journal-title":"Alcohol"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0157|cit157","unstructured":"Bupropion as a smoking cessation aid in alcoholics clinicaltrials.gov\/ct2\/show\/NCT00044434"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0158|cit158","doi-asserted-by":"crossref","unstructured":"Carpenter MJ Baker NL Gray KM Upadhyaya HP Assessment of nicotine dependence among adolescent and young adult smokers: a comparison of measures Addictive Behaviors 2010 35 11 977 82","DOI":"10.1016\/j.addbeh.2010.06.013"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0159|cit159","doi-asserted-by":"crossref","unstructured":"Gray KM Carpenter MJ Baker NL Hartwell KJ Lewis AL Hiott DW Bupropion SR and contingency management for adolescent smoking cessation Journal of Substance Abuse Treatment 2011 40 1 77 86","DOI":"10.1016\/j.jsat.2010.08.010"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0160|cit160","unstructured":"Gray KM Carpenter MJ Baker NL Klintworth EM Leinbach AS Upadhyaya HP Bupropion SR and contingency management in adolescent smokers: main findings College on Problems of Drug Dependence 71st Annual Meeting; 2009 June 20-25; Reno\/Sparks (NV) 2009 74"},{"issue":"2","key":"10.1002\/14651858.CD000031.pub6-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ntr\/ntr130","article-title":"Varenicline versus bupropion XL for smoking cessation in older adolescents: a randomized, double-blind pilot trial","volume":"14","author":"Gray","year":"2012","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pupt.2005.05.003","article-title":"A controlled trial of nortriptyline, sustained-release bupropion and placebo for smoking cessation: preliminary results","volume":"19","author":"Haggstr\u00e4m","year":"2006","journal-title":"Pulmonary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1037\/0022-006X.72.4.563","article-title":"Influences of mood, depression history, and treatment modality on outcomes in smoking cessation","volume":"72","author":"Haas","year":"2004","journal-title":"Journal of Consulting & Clinical Psychology"},{"issue":"4","key":"10.1002\/14651858.CD000031.pub6-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/14622200701239480","article-title":"Belief about drug assignment and abstinence in treatment of cigarette smoking using nortriptyline","volume":"9","author":"Hall","year":"2007","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/archpsyc.55.8.683","article-title":"Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking","volume":"55","author":"Hall","year":"1998","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/sj.clpt.6100307","article-title":"Therapeutic drug monitoring of nortriptyline in smoking cessation: a multistudy analysis","volume":"83","author":"Mooney","year":"2008","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD000031.pub6-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/14622200701239480","article-title":"Belief about drug assignment and abstinence in treatment of cigarette smoking using nortriptyline","volume":"9","author":"Hall","year":"2007","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0168|cit168","unstructured":"Hall SM Humfleet G Maude-Griffin R Reus VI Munoz R Hartz DT Nortriptyline versus bupropion and medical management versus psychological intervention in smoking treatment (PA 5A) Society for Research on Nicotine and Tobacco 7th Annual Meeting; 2001 March 23; Seattle (WA) 2001 31"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/archpsyc.59.10.930","article-title":"Psychological intervention and antidepressant treatment in smoking cessation","volume":"59","author":"Hall","year":"2002","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF02384199","article-title":"Cost-effectiveness of bupropion, nortriptyline, and psychological intervention in smoking cessation","volume":"32","author":"Hall","year":"2005","journal-title":"Journal of Behavioral Health Services & Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/sj.clpt.6100307","article-title":"Therapeutic drug monitoring of nortriptyline in smoking cessation: a multistudy analysis","volume":"83","author":"Mooney","year":"2008","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1176\/appi.ajp.161.11.2100","article-title":"Extended nortriptyline and psychological treatment for cigarette smoking","volume":"161","author":"Hall","year":"2004","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/sj.clpt.6100307","article-title":"Therapeutic drug monitoring of nortriptyline in smoking cessation: a multistudy analysis","volume":"83","author":"Mooney","year":"2008","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00004714-200102000-00017","article-title":"A preliminary study of bupropion sustained-release for smoking cessation in patients with chronic posttraumatic stress disorder","volume":"21","author":"Hertzberg","year":"2001","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0175|cit175","doi-asserted-by":"crossref","unstructured":"Hilberink SR Jacobs JE Breteler MH de Vries H Grol RP General practice counseling for patients with chronic obstructive pulmonary disease to quit smoking: Impact after 1 year of two complex interventions Patient Education and Counseling 2011 83 1 120 4","DOI":"10.1016\/j.pec.2010.04.009"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0176|cit176","unstructured":"Hoch E Wittchen HU Population health perspective on smoking cessation: a randomized controlled trial of different methods in primary health care (RPOS 3-71) Society for Research on Nicotine and Tobacco 12th Annual Meeting; 2006 February 15-18; Orlando (FL) 2006"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0177|cit177","first-page":"137","article-title":"Smoking cessation in primary care: implementation effectiveness and optimized allocation","volume":"5","author":"Sonntag","year":"2003","journal-title":"Suchtmedizin in Forschung und Praxis"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/thx.2004.030239","article-title":"Efficacy of bupropion in the indigenous Maori population in New Zealand","volume":"60","author":"Holt","year":"2005","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1378\/chest.119.5.1357","article-title":"Bupropion for smoking cessation: predictors of successful outcome","volume":"119","author":"Dale","year":"2001","journal-title":"Chest"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0180|cit180","unstructured":"Presentation for FDA approval of bupropion sustained release for smoking cessation (10 December 1996) Dr J Andrew Johnston"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1192\/bjp.174.2.173","article-title":"Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism","volume":"174","author":"Hayford","year":"1999","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0182|cit182","first-page":"137","article-title":"Bupropion for smoking cessation: a double-blind, placebo-controlled dose response trial","volume":"15","author":"Hurt","year":"1996","journal-title":"Journal of Addictive Diseases"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJM199710233371703","article-title":"A comparison of sustained-release bupropion and placebo for smoking cessation","volume":"337","author":"Hurt","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/14622200110042852","article-title":"Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation","volume":"3","author":"Johnston","year":"2001","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/annonc\/mdx087.004","article-title":"The efficacy of combination therapy with varenicline and bupropion for smoking cessation","volume":"28 Suppl 2","author":"Johns","year":"2017","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"213","DOI":"10.5993\/AJHB.26.3.6","article-title":"Impact of prior nicotine replacement therapy on smoking cessation efficacy","volume":"26","author":"Durcan","year":"2002","journal-title":"American Journal of Health Behavior"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0149-2918(01)80023-0","article-title":"Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo","volume":"23","author":"Jamerson","year":"2001","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199903043400903","article-title":"A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation","volume":"340","author":"Jorenby","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/pmed.1999.0627","article-title":"Cost-benefit analysis of sustained-release bupropion, nicotine patch, or both for smoking cessation","volume":"30","author":"Nielsen","year":"2000","journal-title":"Preventive Medicine"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/1462220021000060437","article-title":"Targeting smokers at increased risk for relapse: treating women and those with a history of depression","volume":"5","author":"Smith","year":"2003","journal-title":"Nicotine & Tobacco Research"},{"issue":"2","key":"10.1002\/14651858.CD000031.pub6-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/eurpub\/ckq137","article-title":"Changes in health-related quality of life with smoking cessation treatment","volume":"22","author":"Hays","year":"2012","journal-title":"European Journal of Public Health"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0192|cit192","doi-asserted-by":"crossref","unstructured":"Hays JT Leischow SJ Lawrence D Lee TC Adherence to treatment for tobacco dependence: association with smoking abstinence and predictors of adherence Nicotine & Tobacco Research 2010 12 6 574 81","DOI":"10.1093\/ntr\/ntq047"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.296.1.56","article-title":"Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial","volume":"296","author":"Jorenby","year":"2006","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD000031.pub6-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/npp.2011.232","article-title":"Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials","volume":"37","author":"King","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD000031.pub6-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00213-007-1041-3","article-title":"Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt","volume":"197","author":"West","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0196|cit196","doi-asserted-by":"crossref","unstructured":"Kahn R Gorgon L Jones K McSherry F Glover ED Anthenelli RM Selegiline transdermal system (STS) as an aid for smoking cessation Nicotine & Tobacco Research 2012 14 3 377 82","DOI":"10.1093\/ntr\/ntr143"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0197|cit197","unstructured":"Selegiline for smoking cessation - 1 clinicaltrials.gov\/ct2\/show\/NCT00439413"},{"issue":"2-3","key":"10.1002\/14651858.CD000031.pub6-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.drugalcdep.2011.03.005","article-title":"Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, double-blind, placebo-controlled study","volume":"118","author":"Kalman","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0199|cit199","doi-asserted-by":"crossref","unstructured":"Madden GJ Kalman D Effects of bupropion on simulated demand for cigarettes and the subjective effects of smoking Nicotine & Tobacco Research 2010 12 4 416 22","DOI":"10.1093\/ntr\/ntq018"},{"issue":"6","key":"10.1002\/14651858.CD000031.pub6-BIB0200|cit200","first-page":"923","article-title":"Predictors of relapse in a bupropion trial for smoking cessation in recently-abstinent alcoholics: Preliminary results using an aggregate genetic risk score","volume":"41","author":"McGeary","year":"2011","journal-title":"Behavior Genetics"},{"issue":"1","key":"10.1002\/14651858.CD000031.pub6-BIB0201|cit201","first-page":"107","article-title":"Predictors of relapse in a bupropion trial for smoking cessation in recently-abstinent alcoholics: Preliminary results using an aggregate genetic risk score","volume":"6","author":"McGeary","year":"2012","journal-title":"Substance Abuse: Research and Treatment"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0202|cit202","unstructured":"Effectiveness of bupropion for smokers recovering from alcohol dependence clinicaltrials.gov\/ct2\/show\/NCT00304707"},{"issue":"6","key":"10.1002\/14651858.CD000031.pub6-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3109\/00952990.2011.598591","article-title":"Bupropion-SR for smoking cessation in early recovery from alcohol dependence: a placebo-controlled, double-blind pilot study","volume":"37","author":"Karam-Hage","year":"2011","journal-title":"American Journal of Drug and Alcohol Abuse"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0204|cit204","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0306-4603(01)00266-0","article-title":"Onset of major depression during treatment for nicotine dependence","volume":"28","author":"Killen","year":"2003","journal-title":"Addictive Behaviors"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1037\/0022-006X.68.5.883","article-title":"Nicotine patch and paroxetine for smoking cessation","volume":"68","author":"Killen","year":"2000","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.addbeh.2004.02.029","article-title":"Major depression among adolescent smokers undergoing treatment for nicotine dependence","volume":"29","author":"Killen","year":"2004","journal-title":"Addictive Behaviors"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0207|cit207","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1037\/0022-006X.72.4.729","article-title":"Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers","volume":"72","author":"Killen","year":"2004","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0208|cit208","doi-asserted-by":"crossref","unstructured":"Killen JD Fortmann SP Murphy GM Hayward C Fong D Lowenthal K Failure to improve cigarette smoking abstinence with transdermal selegiline + cognitive behavior therapy Addiction 2010 105 9 1660 8","DOI":"10.1111\/j.1360-0443.2010.03020.x"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0209|cit209","unstructured":"Selegiline patch for treatment of nicotine dependence clinicaltrials.gov\/ct2\/show\/NCT01330030"},{"issue":"9","key":"10.1002\/14651858.CD000031.pub6-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/ntr\/ntu273","article-title":"Response to transdermal selegiline smoking cessation therapy and markers in the 15q24 chromosomal region","volume":"17","author":"Sarginson","year":"2015","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0211|cit211","unstructured":"A study to evaluate different strategies (medicine, enhanced counselling, standard counselling) for stopping smoking in TB patients in TB program in India apps.who.int\/trialsearch\/Trial2.aspx?TrialID=CTRI\/2013\/07\/003830"},{"issue":"1","key":"10.1002\/14651858.CD000031.pub6-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijtb.2020.01.006","article-title":"Strategies for smoking cessation (pharmacologic intervention versus enhanced motivation vs. standard motivation) in TB patients under treatment in the RNTCP, India - a cluster randomized trial","volume":"67","author":"Kumar","year":"2020","journal-title":"Indian Journal of Tuberculosis"},{"issue":"5","key":"10.1002\/14651858.CD000031.pub6-BIB0213|cit213","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/ntr\/ntu192","article-title":"A test of the stress-buffering model of social support in smoking cessation: is the relationship between social support and time to relapse mediated by reduced withdrawal symptoms?","volume":"17","author":"Creswell","year":"2015","journal-title":"Nicotine & Tobacco Research"},{"issue":"4","key":"10.1002\/14651858.CD000031.pub6-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1037\/a0028948","article-title":"Dietary intake after smoking cessation among weight-concerned women smokers","volume":"26","author":"Levine","year":"2012","journal-title":"Psychology of Addictive Behaviors"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0215|cit215","doi-asserted-by":"crossref","unstructured":"Levine MD Perkins KA Kalarchian MA Cheng Y Houck PR Slane JD Bupropion and cognitive behavioural therapy for weight-concerned women smokers Archives of Internal Medicine 2010 170 6 543 50","DOI":"10.1001\/archinternmed.2010.33"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0216|cit216","doi-asserted-by":"crossref","unstructured":"Okun ML Levine MD Houck P Perkins KA Marcus MD Subjective sleep disturbance during a smoking cessation program: associations with relapse Addictive Behaviors 2011 36 8 861 4","DOI":"10.1016\/j.addbeh.2011.03.001"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0217|cit217","doi-asserted-by":"crossref","unstructured":"McCarthy DE Piasecki TM Jorenby DE Lawrence DL Shiffman S Baker TB A multi-level analysis of non-significant counseling effects in a randomized smoking cessation trial Addiction 2010 105 12 2195 208","DOI":"10.1111\/j.1360-0443.2010.03089.x"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0218|cit218","unstructured":"McCarthy DE Piasecki TM Lawrence DL Fiore MC Baker TB Efficacy of bupropion SR and individual counseling among adults attempting to quit smoking (POS1-041) Society for Research on Nicotine and Tobacco 10th Annual Meeting; 2004 February 18-21; Phoenix (AZ) 2004"},{"issue":"9","key":"10.1002\/14651858.CD000031.pub6-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1360-0443.2008.02275.x","article-title":"Psychological mediators of bupropion sustained-release treatment for smoking cessation","volume":"103","author":"McCarthy","year":"2008","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0220|cit220","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1080\/14622200801968343","article-title":"A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling","volume":"10","author":"McCarthy","year":"2008","journal-title":"Nicotine & Tobacco Research"},{"issue":"9-B","key":"10.1002\/14651858.CD000031.pub6-BIB0221|cit221","first-page":"5414","article-title":"Mechanisms of tobacco cessation treatment: Self-report mediators of counseling and bupropion sustained release treatment","volume":"67","author":"McCarthy","year":"2007","journal-title":"Dissertation Abstracts International: Section B: The Sciences and Engineering"},{"issue":"1","key":"10.1002\/14651858.CD000031.pub6-BIB0222|cit222","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1037\/adb0000017","article-title":"Using ecological measures of smoking trigger exposure to predict smoking cessation milestones","volume":"29","author":"Minami","year":"2015","journal-title":"Psychology of Addictive Behaviors"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0223|cit223","unstructured":"Bupropion SR plus counseling for smoking cessation clinicaltrials.gov\/ct2\/show\/NCT01621009"},{"issue":"5","key":"10.1002\/14651858.CD000031.pub6-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1037\/a0037156","article-title":"Effects of sequential fluoxetine and gender on prequit depressive symptoms, affect, craving, and quit day abstinence in smokers with elevated depressive symptoms: a growth curve modeling approach","volume":"22","author":"Minami","year":"2014","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD000031.pub6-BIB0225|cit225","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1590\/0101-60830000000099","article-title":"Predictors of retention in a multicomponent treatment for smokers","volume":"43","author":"Moreno-Coutino","year":"2016","journal-title":"Revista de Psiquiatria Clinica"},{"issue":"6","key":"10.1002\/14651858.CD000031.pub6-BIB0226|cit226","doi-asserted-by":"crossref","first-page":"433","DOI":"10.17711\/SM.0185-3325.2015.058","article-title":"Assessment of depressive symptoms in severe smokers with minimal-mild depressive symptomatology receiving pre-smoking abstinence for integrated treatment: a randomized clinical trial","volume":"38","author":"Moreno-Couti\u00f1o","year":"2015","journal-title":"Salud Mental"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0227|cit227","doi-asserted-by":"crossref","unstructured":"Best D Bupropion assists with tobacco cessation in adolescents but relapse is high Journal of Pediatrics 2008 152 5 738 9","DOI":"10.1016\/j.jpeds.2008.02.021"},{"issue":"1","key":"10.1002\/14651858.CD000031.pub6-BIB0228|cit228","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/oby.21360","article-title":"BMI changes in adolescents treated with bupropion SR for smoking cessation","volume":"24","author":"Floden","year":"2016","journal-title":"Obesity"},{"issue":"5","key":"10.1002\/14651858.CD000031.pub6-BIB0229|cit229","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1093\/ntr\/ntv179","article-title":"Adolescent smoking cessation with bupropion: the role of adherence","volume":"18","author":"Leischow","year":"2016","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0230|cit230","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1001\/archpedi.161.11.1068","article-title":"Randomized, double-blind, placebo-controlled trial of 2 dosages of sustained-release bupropion for adolescent smoking cessation","volume":"161","author":"Muramoto","year":"2007","journal-title":"Archives of Pediatrics & Adolescent Medicine"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0231|cit231","unstructured":"Taren D Fankem S Muramoto M Weight loss in adolescents who quit smoking with bupropion [RP-071] Society for Research on Nicotine and Tobacco 11th Annual Meeting; 2005 March 20-23; Prague, Czech Republic. Rapid communications posters 2005"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0232|cit232","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1365-2044.2004.03943.x","article-title":"Effectiveness of bupropion as an aid to stopping smoking before elective surgery: a randomised controlled trial","volume":"59","author":"Myles","year":"2004","journal-title":"Anaesthesia"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0233|cit233","unstructured":"Impact of smoking cessation on sleep - 5 clinicaltrials.gov\/ct2\/show\/NCT00132821"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0234|cit234","unstructured":"Nicotine patch and bupropion to reduce smoking rates in younger, low-income, and minority individuals clinicaltrials.gov\/ct2\/show\/NCT00308763"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0235|cit235","unstructured":"The pharmacogenetic study, readiness to change, and pharmacological intervention for smoking cessation in schizophrenia clinicaltrials.gov\/ct2\/show\/NCT00495352"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0236|cit236","unstructured":"Sequential use of fluoxetine for smokers with elevated depressive symptoms clinicaltrials.gov\/ct2\/show\/NCT00578669"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0237|cit237","unstructured":"Mechanistic evaluations of pre-cessation therapies for smoking cessation clinicaltrials.gov\/ct2\/show\/NCT01406223"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0238|cit238","doi-asserted-by":"crossref","first-page":"534","DOI":"10.4088\/JCP.v57n1106","article-title":"Development of major depressive disorder during smoking-cessation treatment","volume":"57","author":"Borrelli","year":"1996","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0239|cit239","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1360-0443.2004.00648.x","article-title":"Experimenter-defined quit dates for smoking cessation: adherence improves outcomes for women but not for men","volume":"99","author":"Borrelli","year":"2004","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0240|cit240","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1037\/0022-006X.69.3.511","article-title":"Influences of gender and weight gain on short-term relapse to smoking in a cessation trial","volume":"69","author":"Borrelli","year":"2001","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0241|cit241","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1037\/0022-006X.67.1.124","article-title":"Weight suppression and weight rebound in ex-smokers treated with fluoxetine","volume":"67","author":"Borrelli","year":"1999","journal-title":"Journal of Consulting and Clinical Psychiatry"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0242|cit242","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00213-003-1711-8","article-title":"Influence of fluoxetine on positive and negative affect in a clinic-based smoking cessation trial","volume":"173","author":"Cook","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0243|cit243","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1037\/0893-164X.20.1.36","article-title":"Elevated positive mood: a mixed blessing for abstinence","volume":"20","author":"Doran","year":"2006","journal-title":"Psychology of Addictive Behaviors"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0244|cit244","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1037\/1064-1297.9.4.355","article-title":"Influence of antidepressant pharmacotherapy on behavioral treatment adherence and smoking cessation outcome in a combined treatment involving fluoxetine","volume":"9","author":"Hitsman","year":"2001","journal-title":"Experimental & Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0245|cit245","first-page":"491","article-title":"Fluoxetine and weight-gain in smoking cessation - examination of actual weight-gain and fear of weight-gain [abstract]","volume":"32","author":"Mizes","year":"1996","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0246|cit246","unstructured":"Niaura R Goldstein M Spring B Keuthen N Kristeller J DePue J Fluoxetine for smoking cessation: a multicenter randomized double blind dose response study Society for Behavioral Medicine Annual Meeting; 1997 April 18; San Francisco (CA) 1997"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0247|cit247","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1037\/0022-006X.70.4.887","article-title":"Multicenter trial of fluoxetine as an adjunct to behavioral smoking cessation treatment","volume":"70","author":"Niaura","year":"2002","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0248|cit248","first-page":"281","article-title":"Subgroups of smokers with different success rates after treatment with fluoxetine for smoking cessation [abstract]","volume":"1","author":"Swan","year":"1999","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0249|cit249","unstructured":"A seven-week dose-ranging study of CP-526,555 compared with placebo and zyban for smoking cessation clinicaltrials.gov\/ct2\/show\/NCT00150241"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0250|cit250","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/archinte.166.15.1561","article-title":"Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up","volume":"166","author":"Nides","year":"2006","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0251|cit251","unstructured":"Oncken C Watsky E Reeves K Anziano R Varenicline is efficacious and well tolerated in promoting smoking cessation: results from a 7-week, randomized, placebo- and bupropion-controlled trial Society for Research on Nicotine and Tobacco 11th Annual Meeting; 2005 March 20-23; Prague, Czech Republic 2005"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0252|cit252","unstructured":"A 2x2 phase II randomized controlled trial to investigate the efficacy of NRT plus St John's wort versus NRT plus placebo in smoking cessation and to examine the efficacy of chromium nicotinate versus placebo in preventing weight gain while stopping smoking. SJW and chromium in smoking cessation clinicaltrialsregister.eu\/ctr-search\/search?query=2005-000662-39"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0253|cit253","unstructured":"A 2 x 2 phase II randomised controlled trial to investigate the efficacy of St John's wort versus placebo in smoking cessation and the efficacy of chromium intake in preventing weight gain isrctn.com\/ISRCTN31302738"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0254|cit254","doi-asserted-by":"crossref","unstructured":"Parsons A Ingram J Inglis J Aveyard P Johnstone E Brown K A proof of concept randomised placebo controlled factorial trial to examine the efficacy of St John's wort for smoking cessation and chromium to prevent weight gain on smoking cessation Drug and Alcohol Dependence 2009 102 1-3 116 22","DOI":"10.1016\/j.drugalcdep.2009.02.006"},{"issue":"11","key":"10.1002\/14651858.CD000031.pub6-BIB0255|cit255","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1111\/add.12273","article-title":"Sensitivity and specificity of a procedure for early human screening of novel smoking cessation medications","volume":"108","author":"Perkins","year":"2013","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0256|cit256","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.drugalcdep.2017.07.037","article-title":"Evaluating the effect of smoking cessation treatment on a complex dynamical system","volume":"180","author":"Bekiroglu","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0257|cit257","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1080\/14622200701540820","article-title":"Efficacy of bupropion alone and in combination with nicotine gum","volume":"9","author":"Piper","year":"2007","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0258|cit258","unstructured":"Piper ME Federman EB McCarthy DE Bolt DM Smith SS Fiore MC Mediators of bupropion treatment effects (SYM 2C) Society for Research on Nicotine and Tobacco 14th Annual Meeting; 2008 Feb 26 - Mar 1; Portland (OR) 2008 31"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0259|cit259","unstructured":"Piper ME Federman EB Smith SS Fiore MC Baker TB Efficacy of bupropion SR alone and combined with 4-mg gum (PA2-2) Society for Research on Nicotine and Tobacco 10th Annual Meeting; 2004 February 18-21, Phoenix (AZ) 2004 18"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0260|cit260","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1037\/0021-843X.117.1.94","article-title":"Using mediational models to explore the nature of tobacco motivation and tobacco treatment effects","volume":"117","author":"Piper","year":"2008","journal-title":"Journal of Abnormal Psychology"},{"issue":"9-B","key":"10.1002\/14651858.CD000031.pub6-BIB0261|cit261","first-page":"5418","article-title":"Bupropion alone and in combination with nicotine gum: Efficacy, mediation and moderation","volume":"67","author":"Piper","year":"2007","journal-title":"Dissertation Abstracts International: Section B: The Sciences and Engineering"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0262|cit262","doi-asserted-by":"crossref","unstructured":"Asthana A Johnson HM Piper ME Fiore MC Baker TB Stein JH Effects of smoking intensity and cessation on inflammatory markers in a large cohort of active smokers American Heart Journal 2010 160 3 458 63","DOI":"10.1016\/j.ahj.2010.06.006"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000031.pub6-BIB0263|cit263","first-page":"99","article-title":"Alcohol use after tobacco cessation: immediate consequences","volume":"27","author":"Berg","year":"2012","journal-title":"Journal of General Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD000031.pub6-BIB0264|cit264","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1037\/a0026366","article-title":"Why two smoking cessation agents work better than one: role of craving suppression","volume":"80","author":"Bolt","year":"2012","journal-title":"Journal of Consulting and Clinical Psychology"},{"issue":"1","key":"10.1002\/14651858.CD000031.pub6-BIB0265|cit265","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/add.12353","article-title":"Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6)","volume":"109","author":"Chen","year":"2014","journal-title":"Addiction"},{"issue":"6","key":"10.1002\/14651858.CD000031.pub6-BIB0266|cit266","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/ntr\/ntw247","article-title":"Anhedonia: its dynamic relations with craving, negative affect, and treatment during a quit smoking attempt","volume":"19","author":"Cook","year":"2017","journal-title":"Nicotine & Tobacco Research"},{"issue":"2","key":"10.1002\/14651858.CD000031.pub6-BIB0267|cit267","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/ntr\/ntz044","article-title":"Variants in the CHRNA5-CHRNA3-CHRNB4 region of chromosome 15 predict gastrointestinal adverse events in the TTURC smoking cessation trial","volume":"22","author":"Culverhouse","year":"2019","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0268|cit268","doi-asserted-by":"crossref","unstructured":"Gepner AD Piper ME Johnson HM Fiore MC Baker TB Stein JH Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial American Heart Journal 2011 161 1 145 51","DOI":"10.1016\/j.ahj.2010.09.023"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0269|cit269","doi-asserted-by":"crossref","unstructured":"Japuntich SJ Leventhal AM Piper ME Bolt DM Roberts LJ Fiore MC Smoker characteristics and smoking-cessation milestones American Journal of Preventive Medicine 2011 40 3 286 94","DOI":"10.1016\/j.amepre.2010.11.016"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0270|cit270","doi-asserted-by":"crossref","unstructured":"Japuntich SJ Piper ME Leventhal AM Bolt DM Baker TB The effect of five smoking cessation pharmacotherapies on smoking cessation milestones Journal of Consulting and Clinical Psychology 2011 79 1 34 42","DOI":"10.1037\/a0022154"},{"issue":"2","key":"10.1002\/14651858.CD000031.pub6-BIB0271|cit271","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/ntr\/ntr147","article-title":"Should all smokers use combination smoking cessation pharmacotherapy? Using novel analytic methods to detect differential treatment effects over 8 weeks of pharmacotherapy","volume":"14","author":"Loh","year":"2012","journal-title":"Nicotine & Tobacco Research"},{"issue":"4","key":"10.1002\/14651858.CD000031.pub6-BIB0272|cit272","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1037\/ccp0000017","article-title":"Paths to tobacco abstinence: A repeated-measures latent class analysis","volume":"83","author":"McCarthy","year":"2015","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0273|cit273","doi-asserted-by":"crossref","unstructured":"Piper ME Cook JW Schlam TR Jorenby DE Baker TB Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment Addiction 2011 106 2 418 27","DOI":"10.1111\/j.1360-0443.2010.03173.x"},{"issue":"6","key":"10.1002\/14651858.CD000031.pub6-BIB0274|cit274","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/ntr\/ntq067","article-title":"Gender, race, and education differences in abstinence rates among participants in two randomized smoking cessation trials","volume":"12","author":"Piper","year":"2010","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0275|cit275","doi-asserted-by":"crossref","unstructured":"Piper ME Kenford S Fiore MC Baker TB Smoking cessation and quality of life: changes in life satisfaction over 3 years following a quit attempt Annals of Behavioral Medicine 2012 43 2 262 70","DOI":"10.1007\/s12160-011-9329-2"},{"issue":"4","key":"10.1002\/14651858.CD000031.pub6-BIB0276|cit276","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00213-011-2250-3","article-title":"Tobacco withdrawal components and their relations with cessation success","volume":"216","author":"Piper","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0277|cit277","doi-asserted-by":"crossref","unstructured":"Piper ME Smith SS Schlam TR Fiore MC Jorenby DE Fraser D A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies Archives of General Psychiatry 2009 66 11 1253 62","DOI":"10.1001\/archgenpsychiatry.2009.142"},{"issue":"12","key":"10.1002\/14651858.CD000031.pub6-BIB0278|cit278","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1111\/add.12661","article-title":"Smoking cessation in smokers who smoke menthol and non-menthol cigarettes","volume":"109","author":"Smith","year":"2014","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0279|cit279","doi-asserted-by":"crossref","unstructured":"Planer D Lev I Elitzur Y Sharon N Ouzan E Pugatsch T Bupropion for smoking cessation in patients with acute coronary syndrome Archives of Internal Medicine 2011 171 12 1055 60","DOI":"10.1001\/archinternmed.2011.72"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0280|cit280","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/archinte.158.18.2035","article-title":"A randomized trial of nortriptyline for smoking cessation","volume":"158","author":"Prochazka","year":"1998","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0281|cit281","unstructured":"Combined nortriptyline and transdermal nicotine for smoking cessation clinicaltrials.gov\/ct2\/show\/NCT00018148"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0282|cit282","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1001\/archinte.164.20.2229","article-title":"A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation","volume":"164","author":"Prochazka","year":"2004","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0283|cit283","unstructured":"Prochazka AV Reyes R Steinbrunn C Miyoshi T Randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation (PO3 26) Society for Research on Nicotine and Tobacco 7th Annual Meeting; 2001 March 23; Seattle (WA) 2001 73"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0284|cit284","unstructured":"Individual tobacco cessation research based on nicotine metabolite ratio in smoking patients with chronic obstructive pulmonary disease: a randomized controlled trial https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=ChiCTR1900021400"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0285|cit285","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2147\/COPD.S301579","article-title":"Adherence and efficacy of smoking cessation treatment among patients with COPD in China","volume":"16","author":"Qin","year":"2021","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"issue":"5","key":"10.1002\/14651858.CD000031.pub6-BIB0286|cit286","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/add.12084","article-title":"A randomized controlled trial of a smoking cessation intervention conducted among prisoners","volume":"108","author":"Richmond","year":"2013","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0287|cit287","first-page":"682","article-title":"Safety and efficacy of bupropion for smokers hospitalized with acute cardiovascular disease [abstract]","volume":"7","author":"Rigotti","year":"2005","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0288|cit288","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.amjmed.2006.04.024","article-title":"Bupropion for smokers hospitalized with acute cardiovascular disease","volume":"119","author":"Rigotti","year":"2006","journal-title":"American Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD000031.pub6-BIB0289|cit289","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archinternmed.2007.60","article-title":"Depressive symptoms and smoking cessation after hospitalization for cardiovascular disease","volume":"168","author":"Thorndike","year":"2008","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0290|cit290","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1176\/appi.ajp.2013.12070919","article-title":"Adapting smoking cessation treatment according to initial response to precessation nicotine patch","volume":"170","author":"Rose","year":"2013","journal-title":"American Journal of Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD000031.pub6-BIB0291|cit291","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1176\/appi.ajp.2014.13050595","article-title":"Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm","volume":"171","author":"Rose","year":"2014","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0292|cit292","unstructured":"Rose JE Behm FM Combination varenicline\/bupropion treatment benefits male NRT-nonresponders Society for Research on Nicotine and Tobacco 19th Annual Meeting; 2013 March 13-16; Boston (MA) 2013 261"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0293|cit293","unstructured":"Combination bupropion\/varenicline for smoking cessation in male smokers clinicaltrials.gov\/ct2\/show\/NCT01806779"},{"issue":"8","key":"10.1002\/14651858.CD000031.pub6-BIB0294|cit294","first-page":"999","article-title":"Combination varenicline\/bupropion treatment benefits highly dependent smokers in an adaptive smoking cessation paradigm","volume":"19","author":"Rose","year":"2017","journal-title":"Nicotine & Tobacco Research"},{"issue":"Suppl 38","key":"10.1002\/14651858.CD000031.pub6-BIB0295|cit295","first-page":"611s","article-title":"Evaluation of prolonged bupropion treatment as an aid in smoking cessation [abstract]","volume":"20","author":"Gratziou","year":"2002","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0296|cit296","unstructured":"Rovina N Gratziou C Nikoloutsou I Athanassa Z Francis K Roussos C Ideal duration of therapy with bupropion HCL: comparison between short and long treatment Abstract Book: Society for Research on Nicotine and Tobacco 5th European Meeting; 2003 November 20-22; Padua, Italy 2003"},{"issue":"Suppl 45","key":"10.1002\/14651858.CD000031.pub6-BIB0297|cit297","first-page":"165s","article-title":"Short or prolonged treatment with bupropion HCL in smoking cessation therapy","volume":"22","author":"Rovina","year":"2003","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0298|cit298","doi-asserted-by":"crossref","unstructured":"Rovina N Nikoloutsou I Katsani G Dima E Fransis K Roussos C Effectiveness of pharmacotherapy and behavioral interventions for smoking cessation in actual clinical practice Therapeutic Advances in Respiratory Disease 2009 3 6 279 87","DOI":"10.1177\/1753465809350653"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0299|cit299","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1080\/10550490490512762","article-title":"Double-blind placebo-controlled trial of fluoxetine in smoking cessation treatment including nicotine patch and cognitive-behavioral group therapy","volume":"13","author":"Saules","year":"2004","journal-title":"American Journal on Addictions"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0300|cit300","unstructured":"Schuh LM Downey KK Hopper JA Tancer M Schuster CR Fluoxetine in smoking cessation treatment College on Problems of Drug Dependence 62nd Annual Meeting; 2000 June 17-20; San Juan, Puerto Rico 2000"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0301|cit301","unstructured":"Schepis TS Warren KA Rao U Evaluation of a cognitive-behavioral smoking cessation treatment for adolescents and young adults (POS2-53) Society for Research on Nicotine and Tobacco 12th Annual Meeting; 2006 February 15-18; Orlando (FL) 2006"},{"issue":"6","key":"10.1002\/14651858.CD000031.pub6-BIB0302|cit302","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1080\/14622200701365335","article-title":"Bupropion and cognitive-behavioral therapy for smoking cessation in women","volume":"9","author":"Schmitz","year":"2007","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0303|cit303","doi-asserted-by":"crossref","unstructured":"Martinez E Tatum KL Weber DM Kuzla N Pendley A Campbell K Issues related to implementing a smoking cessation clinical trial for cancer patients Cancer Causes & Control 2009 20 1 97 104","DOI":"10.1007\/s10552-008-9222-x"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0304|cit304","unstructured":"Schnoll R Lazev A Sobel M Tatum K Butler D Lerman C Preliminary results from a randomized trial of bupropion for smoking cessation among cancer patients Society for Research on Nicotine and Tobacco 11th Annual Meeting; 2005 March 20-23; Prague, Czech Republic 2005"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0305|cit305","doi-asserted-by":"crossref","unstructured":"Schnoll RA Martinez E Langer C Miyamoto C Leone F Predictors of smoking cessation among cancer patients enrolled in a smoking cessation program Acta Oncologica 2011 50 5 678 84","DOI":"10.3109\/0284186X.2011.572915"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0306|cit306","doi-asserted-by":"crossref","unstructured":"Schnoll RA Martinez E Tatum KL Weber DM Kuzla N Glass M A bupropion smoking cessation clinical trial for cancer patients Cancer Causes & Control 2010 21 6 811 20","DOI":"10.1007\/s10552-010-9507-8"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0307|cit307","unstructured":"GlaxoSmithKline Clinical Trials Register Study No: ZYB40001. A randomized, double-blind, placebo-controlled, 12-week smoking cessation trial of Zyban (150 mg bid) in adult smokers previously treated with Zyban ctr.glaxowellcome.co.uk-Summary-bupropion-IV_ZYB40001.pdf"},{"issue":"7","key":"10.1002\/14651858.CD000031.pub6-BIB0308|cit308","first-page":"A47","article-title":"Sustained-release bupropion (Zybanr) is effective in the re-treatment of relapsed adult smokers","volume":"167","author":"Selby","year":"2003","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0309|cit309","unstructured":"Selby P Brands B Stepner N Retreatment with ZYban SR: 52 week follow-up of a Canadian Multicentre trial (POS3-63) Society for Research on Nicotine and Tobacco 9th Annual Meeting; 2003 February 19-22; New Orleans 2003"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0310|cit310","unstructured":"Selby P Brosky G Baker R Lertzman M Dakin P Roberts J Zyban is effective in the retreatment of relapsed adult smokers (PO4 68) Society for Research on Nicotine and Tobacco 7th Annual Meeting; 2001 March 23; Seattle (WA) 2001 114"},{"issue":"2","key":"10.1002\/14651858.CD000031.pub6-BIB0311|cit311","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/ntr\/nts124","article-title":"Sustained-release bupropion for smoking cessation in a Chinese sample: a double-blind, placebo-controlled, randomized trial","volume":"15","author":"Sheng","year":"2013","journal-title":"Nicotine & Tobacco Research"},{"issue":"6","key":"10.1002\/14651858.CD000031.pub6-BIB0312|cit312","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/ntr\/ntt211","article-title":"Effect of cessation interventions on hookah smoking: post-hoc analysis of a cluster-randomized controlled trial","volume":"16","author":"Dogar","year":"2014","journal-title":"Nicotine & Tobacco Research"},{"issue":"9","key":"10.1002\/14651858.CD000031.pub6-BIB0313|cit313","doi-asserted-by":"crossref","first-page":"667","DOI":"10.7326\/0003-4819-158-9-201305070-00006","article-title":"Action to stop smoking in suspected tuberculosis (assist) in Pakistan: a cluster randomized, controlled trial","volume":"158","author":"Siddiqi","year":"2013","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0314|cit314","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1471-2458-10-160","article-title":"An intervention to stop smoking among patients suspected of TB--evaluation of an integrated approach","volume":"10","author":"Siddiqi","year":"2010","journal-title":"BMC Public Health"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0315|cit315","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/archinte.165.4.470-a","article-title":"The \"bupropion for smoking cessation\" trial from a family practice perspective","volume":"165","author":"Caplan","year":"2005","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0316|cit316","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1001\/archinte.164.16.1797","article-title":"Bupropion for smoking cessation: a randomized trial","volume":"164","author":"Simon","year":"2004","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0317|cit317","first-page":"953","article-title":"Bupropion plus nicotine replacement no better than replacement alone","volume":"53","author":"Simon","year":"2004","journal-title":"Journal of Family Practice"},{"issue":"6","key":"10.1002\/14651858.CD000031.pub6-BIB0318|cit318","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/ntr\/ntp047","article-title":"Sustained-release bupropion for hospital-based smoking cessation: a randomized trial","volume":"11","author":"Simon","year":"2009","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0319|cit319","doi-asserted-by":"crossref","unstructured":"Singh P Kumar R Assessment of the effectiveness of sustained release Bupropion and intensive physician advice in smoking cessation Lung India 2010 27 1 11 8","DOI":"10.4103\/0970-2113.59262"},{"issue":"2","key":"10.1002\/14651858.CD000031.pub6-BIB0320|cit320","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/ntr\/ntr147","article-title":"Should all smokers use combination smoking cessation pharmacotherapy? Using novel analytic methods to detect differential treatment effects over 8 weeks of pharmacotherapy","volume":"14","author":"Loh","year":"2012","journal-title":"Nicotine & Tobacco Research"},{"issue":"6","key":"10.1002\/14651858.CD000031.pub6-BIB0321|cit321","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/ntr\/ntq067","article-title":"Gender, race, and education differences in abstinence rates among participants in two randomized smoking cessation trials","volume":"12","author":"Piper","year":"2010","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0322|cit322","doi-asserted-by":"crossref","unstructured":"Smith SS McCarthy DE Japuntich SJ Christiansen B Piper ME Jorenby DE Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics Archives of Internal Medicine 2009 169 22 2148 55","DOI":"10.1001\/archinternmed.2009.426"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0323|cit323","unstructured":"A multi-center, double-blind, double-dummy, placebo-controlled, randomized, parallel group, dose response evaluation of a new chemical entity (NCE) and Zyban (bupropion hydrochloride) sustained release (300mg\/day) versus placebo as aids to smoking cessation gsk-studyregister.com\/en\/trial-details\/?id=SMK20001"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0324|cit324","unstructured":"St. John's wort for tobacco cessation clinicaltrials.gov\/ct2\/show\/NCT00405912"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0325|cit325","doi-asserted-by":"crossref","unstructured":"Sood A Ebbert JO Prasad K Croghan IT Bauer B Schroeder DR A randomized clinical trial of St. John's wort for smoking cessation Journal of Alternative and Complementary Medicine 2010 16 7 761 7","DOI":"10.1089\/acm.2009.0445"},{"issue":"9","key":"10.1002\/14651858.CD000031.pub6-BIB0326|cit326","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1089\/acm.2011.0462","article-title":"S-Adenosyl-L-methionine (SAMe) for smoking abstinence: a randomized clinical trial","volume":"18","author":"Sood","year":"2012","journal-title":"Journal of Alternative and Complementary Medicine"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0327|cit327","unstructured":"Carrington A Doran N Spring B Fluoxetine moderates the association between trait-anxiety and smoking status following behavioral treatment for smoking cessation (POS4-81) Society for Research on Nicotine and Tobacco 9th Annual Meeting; 2003 February 19-22; New Orleans (LA) 2003"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0328|cit328","unstructured":"Fluoxetine as a quit smoking aid for depression prone clinicaltrials.gov\/ct2\/show\/NCT00113737"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0329|cit329","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1037\/0022-006X.75.1.85","article-title":"Fluoxetine, smoking, and history of major depression: a randomized controlled trial","volume":"75","author":"Spring","year":"2007","journal-title":"Journal of Consulting & Clinical Psychology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0330|cit330","unstructured":"Spring B Doran N Pagoto S McChargue DE Cook JW Bailey K Reduced abstinence for smokers previously treated with fluoxetine (PA1-1) Society for Research on Nicotine and Tobacco 10th Annual Meeting; 2004 February 18-21; Phoenix (AZ) 2004"},{"issue":"12","key":"10.1002\/14651858.CD000031.pub6-BIB0331|cit331","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1111\/add.12304","article-title":"Randomized trial of NRT, bupropion, and NRT plus bupropion for smoking cessation: effectiveness in clinical practice","volume":"108","author":"Stapleton","year":"2013","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0332|cit332","unstructured":"Catz S Jack LM Swan GE McClure J Adherence to bupropion SR in a smoking cessation effectiveness trial (POS2-77) Society for Research on Nicotine and Tobacco 12th Annual Meeting; 2006 February 15-18; Orlando (FL) 2006"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0333|cit333","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0091-7435(03)00011-2","article-title":"Bupropion SR and smoking cessation in actual practice: methods for recruitment, screening, and exclusion for a field trial in a managed-care setting","volume":"36","author":"Jack","year":"2003","journal-title":"Preventive Medicine"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0334|cit334","first-page":"217","article-title":"Cost-effectiveness of different combinations of bupropion SR dose and behavioral treatment for smoking cessation: a societal perspective","volume":"10","author":"Javitz","year":"2004","journal-title":"American Journal of Managed Care"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0335|cit335","unstructured":"McAfee T Zbikowski SM Bush T McClure J Swan G Jack LM The effectiveness of bupropion SR and phone counseling for light and heavy smokers (PA2-1) Society for Research on Nicotine and Tobacco 10th Annual Meeting; 2004 February 18-21; Phoenix (AZ) 2004"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0336|cit336","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1080\/14622200310001646903","article-title":"Bupropion SR and counseling for smoking cessation in actual practice: Predictors of outcome","volume":"5","author":"Swan","year":"2003","journal-title":"Nicotine & Tobacco Research"},{"issue":"3","key":"10.1002\/14651858.CD000031.pub6-BIB0337|cit337","first-page":"239","article-title":"Predictors of 12-month outcome in smokers who received bupropion sustained-release for smoking cessation","volume":"22","author":"Swan","year":"2008","journal-title":"Central Nervous System Drugs"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0338|cit338","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1037\/0278-6133.26.3.361","article-title":"Joint effect of dopaminergic genes on likelihood of smoking following treatment with bupropion SR","volume":"26","author":"Swan","year":"2007","journal-title":"Health Psychology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0339|cit339","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1360-0443.2003.00629.x","article-title":"Heterogeneity in 12-month outcome among female and male smokers","volume":"99","author":"Swan","year":"2004","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0340|cit340","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.163.19.2337","article-title":"Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial","volume":"163","author":"Swan","year":"2003","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0341|cit341","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.tpj.6500281","article-title":"Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR","volume":"5","author":"Swan","year":"2005","journal-title":"Pharmacogenomics Journal"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0342|cit342","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/milmed\/168.10.830","article-title":"Controlled trial for smoking cessation in a Navy shipboard population using nicotine patch, sustained-release bupropion, or both","volume":"168","author":"Swanson","year":"2003","journal-title":"Military Medicine"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0343|cit343","unstructured":"Patel MK Tashkin DP Kanner RE Bailey WC Buist A Anderson PJ A multicenter evaluation of the effects of bupropion hydrochloride sustained release tablets (Bup SR) versus placebo in a population of smokers with chronic obstructive pulmonary disease (PO130) 11th World Conference on Tobacco or Health; 2000 Aug 6-11; Chicago (IL) 2000 118"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0344|cit344","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0140-6736(00)04724-3","article-title":"Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial","volume":"357","author":"Tashkin","year":"2001","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0345|cit345","unstructured":"Contingent incentives plus bupropion for smoking in people with schizophrenia clinicaltrials.gov\/ct2\/show\/NCT00136760"},{"issue":"2","key":"10.1002\/14651858.CD000031.pub6-BIB0346|cit346","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00213-011-2282-8","article-title":"Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia","volume":"217","author":"Tidey","year":"2011","journal-title":"Psychopharmacology"},{"issue":"Suppl 33","key":"10.1002\/14651858.CD000031.pub6-BIB0347|cit347","first-page":"12s","article-title":"Bupropion hydrochloride (Zyban) is effective and well tolerated as an aid to smoking cessation - a multicountry study. Abstract and presentation at 11th Annual meeting of European Respiratory Society, Berlin, September 22-26 2001","volume":"18","author":"Bollinger","year":"2001","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0348|cit348","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1046\/j.1365-2796.2003.01185.x","article-title":"A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation","volume":"254","author":"Tonnesen","year":"2003","journal-title":"Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0349|cit349","unstructured":"Tonstad S Aaserud E Hjalmarson A Peiffer G van der Molen T Hider A Zyban is an effective and well tolerated aid to smoking cessation in a general smoking population - a multi-country study Society for Research on Nicotine and Tobacco 3rd Europe Conference; 2001 September 19-22; Paris, France 2001 46"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0350|cit350","unstructured":"McRobbie H Brath H Astbury C Hider A Sweet R Bupropion hydrochloride sustained release (SR) is an effective and well tolerated aid to smoking cessation in smokers with cardiovascular disease 12 month follow-up phase data (ZYB40014) Abstract and Presentation at European Respiratory Society meeting; 2002 September 14-18; Stockholm, Sweden 2002"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0351|cit351","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0195-668X(03)00003-4","article-title":"Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study","volume":"24","author":"Tonstad","year":"2003","journal-title":"European Heart Journal"},{"issue":"Suppl 33","key":"10.1002\/14651858.CD000031.pub6-BIB0352|cit352","first-page":"13s","article-title":"Bupropion hydrochloride (Zyban) is an effective and well tolerated aid to smoking cessation in smokers with cardiovascular disease - a multicountry study. Abstract and presentation at 11th Annual meeting of European Respiratory Society, Berlin, September 22-26","volume":"18","author":"Spiegel","year":"2001","journal-title":"European Respiratory Journal"},{"issue":"57","key":"10.1002\/14651858.CD000031.pub6-BIB0353|cit353","first-page":"3347","article-title":"Bupropion together with cognitive-conductual therapy (CBT) is an alternative for a long-term abstinence of smoking","volume":"42","author":"Urdapilleta-Herrera","year":"2013","journal-title":"European Respiratory Journal"},{"issue":"Suppl 49","key":"10.1002\/14651858.CD000031.pub6-BIB0354|cit354","first-page":"388s","article-title":"Comparison of nicotine patch and bupropion in treating tobacco dependence","volume":"26","author":"Uyar","year":"2005","journal-title":"European Respiratory Journal"},{"issue":"6","key":"10.1002\/14651858.CD000031.pub6-BIB0355|cit355","first-page":"922","article-title":"A randomized trial of smoking cessation. Medication versus motivation","volume":"28","author":"Uyar","year":"2007","journal-title":"Saudi Medical Journal"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0356|cit356","doi-asserted-by":"crossref","unstructured":"Quaak M van Schayck Constant P Postma Dirkje S Wagena Edwin J van Schooten Frederik J Genetic variants in the serotonin transporter influence the efficacy of bupropion and nortriptyline in smoking cessation Addiction 2012 107 1 178 87","DOI":"10.1111\/j.1360-0443.2011.03534.x"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0357|cit357","doi-asserted-by":"crossref","unstructured":"Van Schayck CP Kaper J Wagena EJ Wouters EF Severens JL The cost-effectiveness of antidepressants for smoking cessation in chronic obstructive pulmonary disease (COPD) patients Addiction 2009 104 12 2110 7","DOI":"10.1111\/j.1360-0443.2009.02723.x"},{"issue":"4","key":"10.1002\/14651858.CD000031.pub6-BIB0358|cit358","first-page":"683","article-title":"Efficacy of bupropion and nortriptyline for smoking cessation among people who are at risk for or have chronic obstructive pulmonary disease: results from a randomized, placebo-controlled trial","volume":"7","author":"Wagena","year":"2005","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0359|cit359","unstructured":"A preliminary study of sustained-release bupropion for smoking cessation in bipolar affective disorder www.clinicaltrials.gov\/ct2\/show\/NCT00593099"},{"issue":"5","key":"10.1002\/14651858.CD000031.pub6-BIB0360|cit360","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/JCP.0b013e318184ba3c","article-title":"A preliminary study of sustained-release bupropion for smoking cessation in bipolar disorder","volume":"28","author":"Weinberger","year":"2008","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0361|cit361","doi-asserted-by":"crossref","unstructured":"Weinberger AH George TP Mckee SA Differences in smoking expectancies in smokers with and without a history of major depression Addictive Behaviors 2011 36 4 434 7","DOI":"10.1016\/j.addbeh.2010.12.024"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0362|cit362","doi-asserted-by":"crossref","unstructured":"Weinberger AH Mckee SA George TP Changes in smoking expectancies in abstinent, reducing, and non-abstinent participants during a pharmacological trial for smoking cessation Nicotine & Tobacco Research 2010 12 9 937 43","DOI":"10.1093\/ntr\/ntq120"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0363|cit363","doi-asserted-by":"crossref","unstructured":"Weinberger AH Reutenauer EL Jatlow PI O'Malley SS Potenza MN George TP A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers Drug and Alcohol Dependence 2010 107 2-3 188 95","DOI":"10.1016\/j.drugalcdep.2009.10.009"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0364|cit364","unstructured":"Weinberger AH Reutenauer EL O'Malley SS Potenza MN George TP A randomized placebo-controlled clinical trial of selegiline for smoking cessation: Preliminary results (POS5-29) Society for Research on Nicotine and Tobacco 15th Annual Meeting; 2009 April 27-30; Dublin, Ireland"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0365|cit365","unstructured":"Weinberger AH Reutenauer EL Solorzano M O'Malley SS Potenza MN George TP A randomized placebo controlled clinical trial of selegiline for smoking cessation (abstract 653) CPDD 71st Annual Meeting; 2009 June 20-25; Reno (NV)"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0366|cit366","doi-asserted-by":"crossref","unstructured":"Mann-Wrobel MC Bennett ME Weiner EE Buchanan RW Ball MP Smoking history and motivation to quit in smokers with schizophrenia in a smoking cessation program Schizophrenia Research 2011 126 1-3 277 83","DOI":"10.1016\/j.schres.2010.10.030"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0367|cit367","doi-asserted-by":"crossref","unstructured":"Weiner E Ball MP Buchholz AS Gold JM Evins AE McMahon RP Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis Journal of Clinical Psychiatry 2012 73 1 95 102","DOI":"10.4088\/JCP.10m06143gre"},{"issue":"5","key":"10.1002\/14651858.CD000031.pub6-BIB0368|cit368","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/14622200500259887","article-title":"A randomized, open-label pilot comparison of gabapentin and bupropion SR for smoking cessation","volume":"7","author":"White","year":"2005","journal-title":"Nicotine & Tobacco Research"},{"issue":"1","key":"10.1002\/14651858.CD000031.pub6-BIB0369|cit369","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/mpr.328","article-title":"Smoking cessation in primary care - a randomized controlled trial of bupropion, nicotine replacements, CBT and a minimal intervention","volume":"20","author":"Wittchen","year":"2011","journal-title":"International Journal of Methods in Psychiatric Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0370|cit370","unstructured":"Puska P Brath H Astbury C Hider AE Zyban is an effective and well tolerated aid to smoking cessation in a healthcare professionals population - a multi-country study Society for Research on Nicotine and Tobacco 3rd European Conference; 2001 September 19-22; Paris, France 2001 45"},{"issue":"Suppl 33","key":"10.1002\/14651858.CD000031.pub6-BIB0371|cit371","first-page":"166s","article-title":"Bupropion hydrochloride sustained release is an effective and well tolerated aid to smoking cessation in a healthcare professionals population - a multicountry study. Abstract and presentation at 11th Annual meeting of European Respiratory Society, Berlin, September 22-26 2001","volume":"18","author":"Zellweger","year":"2001","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0372|cit372","doi-asserted-by":"crossref","first-page":"240","DOI":"10.5993\/AJHB.29.3.5","article-title":"Bupropion SR vs placebo for smoking cessation in health care professionals","volume":"29","author":"Zellweger","year":"2005","journal-title":"American Journal of Health Behavior"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0373|cit373","unstructured":"The MATCH (Medication Aids for Tobacco Cessation and Health) Study clinicaltrials.gov\/ct2\/show\/NCT02146911"},{"issue":"10","key":"10.1002\/14651858.CD000031.pub6-BIB0374|cit374","doi-asserted-by":"crossref","first-page":"e10826","DOI":"10.2196\/10826","article-title":"Varenicline and bupropion for long-term smoking cessation (the MATCH study): protocol for a real-world, pragmatic, randomized controlled trial","volume":"7","author":"Zawertailo","year":"2018","journal-title":"JMIR Research Protocols"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0375|cit375","doi-asserted-by":"crossref","first-page":"109312","DOI":"10.1016\/j.drugalcdep.2022.109312","article-title":"Evaluating the effectiveness of bupropion and varenicline for smoking cessation using an internet-based delivery system: a pragmatic randomized controlled trial (MATCH study)","volume":"232","author":"Zhang","year":"2022","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0376|cit376","first-page":"S35","article-title":"Comparison of the effects of varenicline, bupropion and nicotine replacement therapy on smoking cessation program","volume":"22 Suppl 1","author":"Zincir","year":"2012","journal-title":"Bulletin of Clinical Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD000031.pub6-BIB0377|cit377","doi-asserted-by":"crossref","first-page":"224","DOI":"10.5455\/bcp.20130313045037","article-title":"Comparison of the effectiveness of varenicline, extended-release bupropion and nicotine replacement therapy on the success and the maintenance of a smoking cessation program","volume":"23","author":"Zincir","year":"2013","journal-title":"Klinik Psikofarmakoloji Bulteni"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0378|cit378","unstructured":"Akbarpour F Rezaei O Khodaie-Ardakani MR Sheikhvatan M Goodarzi H Dolatshahi B A double-blind placebo-controlled trial of bupropion for smoking abstinence and cognition improvement in schizophrenia Minerva Psichiatrica 2010 51 4 263 9"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0379|cit379","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12879-016-1727-4","article-title":"A randomized controlled trial of smoking cessation methods in patients newly-diagnosed with pulmonary tuberculosis","volume":"16","author":"Aryanpur","year":"2016","journal-title":"BMC Infectious Diseases"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0380|cit380","doi-asserted-by":"crossref","unstructured":"Banham L Gilbody S Smoking cessation in severe mental illness: what works? Addiction 2010 105 7 1176 89","DOI":"10.1111\/j.1360-0443.2010.02946.x"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0381|cit381","unstructured":"Becker B Bock B Carmona-Barros R St. John's Wort oral spray reduces withdrawal symptoms during quitting smoking (POS4-82) Society for Research on Nicotine and Tobacco 9th Annual Meeting; 2003 February 19-22; New Orleans (LA) 2003"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0382|cit382","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1080\/14622200500259176","article-title":"Lack of effect of D2 dopamine receptor TaqI A polymorphism on smoking cessation","volume":"7","author":"Berlin","year":"2005","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0383|cit383","doi-asserted-by":"crossref","unstructured":"Bloch B Reshef A Cohen T Tafla A Gathas S Israel S Preliminary effects of bupropion and the promoter region (HTTLPR) serotonin transporter (SLC6A4) polymorphism on smoking behavior in schizophrenia Psychiatry Research 2010 175 1-2 38 42","DOI":"10.1016\/j.psychres.2008.12.015"},{"issue":"2","key":"10.1002\/14651858.CD000031.pub6-BIB0384|cit384","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00846173","article-title":"Tryptophan and high-carbohydrate diets as adjuncts to smoking cessation therapy","volume":"14","author":"Bowen","year":"1991","journal-title":"Journal of Behavioral Medicine"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0385|cit385","unstructured":"Brauer LH Paxton DA Stock CT Rose JE Selegiline and transdermal nicotine for smoking cessation Society for Research on Nicotine and Tobacco Annual Conference; 2000 Feb 18-20; Arlington (VA) 2000"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0386|cit386","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/thx.2007.092908","article-title":"High effectiveness of short treatment with bupropion for smoking cessation in general care","volume":"63","author":"Breitling","year":"2008","journal-title":"Thorax"},{"issue":"8","key":"10.1002\/14651858.CD000031.pub6-BIB0387|cit387","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1038\/npp.2013.53","article-title":"Treatment for tobacco dependence: effect on brain nicotinic acetylcholine receptor density","volume":"38","author":"Brody","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0388|cit388","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00406-007-0726-2","article-title":"The efficacy of the combination of sertraline with buspirone for smoking cessation. A randomized clinical trial in nondepressed smokers","volume":"257","author":"Carrao","year":"2007","journal-title":"European Archives of Psychiatry & Clinical Neuroscience"},{"issue":"2","key":"10.1002\/14651858.CD000031.pub6-BIB0389|cit389","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1300\/J069v24n02_02","article-title":"Effectiveness of bupropion for smoking cessation during pregnancy","volume":"24","author":"Chan","year":"2005","journal-title":"Journal of Addictive Diseases"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0390|cit390","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ajp.2015.07.009","article-title":"A comparative study of different modalities of treatment in nicotine dependence syndrome","volume":"17","author":"Chandrashekar","year":"2015","journal-title":"Asian Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0391|cit391","unstructured":"Study for acupoint catgut embedding compared with sustained-release bupropion for treating tobacco dependence trialsearch.who.int\/Trial2.aspx?TrialID=ChiCTR1900020676"},{"issue":"6","key":"10.1002\/14651858.CD000031.pub6-BIB0392|cit392","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/ntr\/ntr263","article-title":"Cost-effectiveness of an intensive smoking cessation intervention for COPD outpatients","volume":"14","author":"Christenhusz","year":"2012","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0393|cit393","first-page":"165","article-title":"Double-blind fluoxetine in depressed alcoholic smokers","volume":"33","author":"Cornelius","year":"1997","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0394|cit394","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00004714-199904000-00015","article-title":"Fluoxetine versus placebo to decrease the smoking of depressed alcoholic patients [letter]","volume":"19","author":"Cornelius","year":"1999","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0395|cit395","first-page":"59","article-title":"Smokers' response to combination bupropion, nicotine patch, and counseling treatment by race\/ethnicity","volume":"18","author":"Covey","year":"2008","journal-title":"Ethnicity & Disease"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0396|cit396","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1360-0443.2007.01887.x","article-title":"A randomized trial of bupropion and\/or nicotine gum as maintenance treatment for preventing smoking relapse","volume":"102","author":"Covey","year":"2007","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0397|cit397","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.addbeh.2005.08.011","article-title":"The prevalence of weight concerns in a smoking abstinence clinical trial","volume":"31","author":"Clark","year":"2006","journal-title":"Addictive Behaviors"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0398|cit398","first-page":"680","article-title":"Comparing nicotine inhaler, bupropion and nicotine inhaler plus bupropion in treating tobacco dependence [abstract]","volume":"7","author":"Croghan","year":"2005","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0399|cit399","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0025-6196(11)60997-X","article-title":"Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention","volume":"82","author":"Croghan","year":"2007","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0400|cit400","doi-asserted-by":"crossref","unstructured":"Croghan IT Hurt RD Ebbert JO Croghan GA Polk Jr OD Stella PJ Racial differences in smoking abstinence rates in a multicenter, randomized, open-label trial in the United States Journal of Public Health 2010 18 1 59 68","DOI":"10.1007\/s10389-009-0277-2"},{"issue":"3","key":"10.1002\/14651858.CD000031.pub6-BIB0401|cit401","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/QAI.0000000000000579","article-title":"An algorithm approach to determining smoking cessation treatment for persons living with HIV\/AIDS: results of a pilot trial","volume":"69","author":"Cropsey","year":"2015","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0402|cit402","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1176\/ajp.152.3.398","article-title":"Mood, major depression, and fluoxetine response in cigarette smokers","volume":"152","author":"Dalack","year":"1995","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD000031.pub6-BIB0403|cit403","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/14622200210153821","article-title":"Bupropion for the treatment of nicotine dependence in spit tobacco users: a pilot study","volume":"4","author":"Dale","year":"2002","journal-title":"Nicotine Tobacco Research"},{"issue":"1","key":"10.1002\/14651858.CD000031.pub6-BIB0404|cit404","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.drugalcdep.2007.02.008","article-title":"Bupropion SR for the treatment of smokeless tobacco use","volume":"90","author":"Dale","year":"2007","journal-title":"Drug & Alcohol Dependence"},{"issue":"9","key":"10.1002\/14651858.CD000031.pub6-BIB0405|cit405","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.addbeh.2005.11.005","article-title":"Measuring nicotine dependence among smokeless tobacco users","volume":"31","author":"Thomas","year":"2006","journal-title":"Addictive Behaviors"},{"issue":"3","key":"10.1002\/14651858.CD000031.pub6-BIB0406|cit406","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1176\/ajp.146.3.373","article-title":"Doxepin as an adjunct to smoking cessation: a double-blind pilot study","volume":"146","author":"Edwards","year":"1989","journal-title":"American Journal of Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD000031.pub6-BIB0407|cit407","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1176\/ajp.147.10.1353","article-title":"Effects of doxepin on withdrawal symptoms in smoking cessation","volume":"147","author":"Murphy","year":"1990","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0408|cit408","unstructured":"Clinical evaluation study: \"Bupropion versus Psychodynamic mental training according to Dr. Grohs for smoke withdrawal\" who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2005-006189-32-AT"},{"issue":"2-3","key":"10.1002\/14651858.CD000031.pub6-BIB0409|cit409","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.schres.2005.02.021","article-title":"A double-blind placebo-controlled cross over trial of bupropion in smoking reduction in schizophrenia","volume":"76","author":"Fatemi","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0410|cit410","first-page":"208","article-title":"The effect of venlafaxine on smoking cessation in subjects with and without a history of depression","volume":"174","author":"Frederick","year":"1997","journal-title":"NIDA Research Monograph"},{"issue":"3","key":"10.1002\/14651858.CD000031.pub6-BIB0411|cit411","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/archpsyc.1989.01810030094013","article-title":"Buspirone reduces smoking [letter]","volume":"46","author":"Gawin","year":"1989","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0412|cit412","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.eurpsy.2019.04.010","article-title":"The effects of transcranial direct current stimulation compared to standard bupropion for the treatment of tobacco dependence: a randomized sham-controlled trial","volume":"60","author":"Ghorbani Behnam","year":"2019","journal-title":"European Psychiatry"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0413|cit413","doi-asserted-by":"crossref","unstructured":"Gifford EV Kohlenberg BS Hayes SC Pierson HM Piasecki MP Antonuccio DO Does acceptance and relationship focused behavior therapy contribute to bupropion outcomes? A randomized controlled trial of functional analytic psychotherapy and acceptance and commitment therapy for smoking cessation Behavior Therapy 2011 42 4 700 15","DOI":"10.1016\/j.beth.2011.03.002"},{"issue":"5","key":"10.1002\/14651858.CD000031.pub6-BIB0414|cit414","doi-asserted-by":"crossref","first-page":"386","DOI":"10.5993\/AJHB.26.5.7","article-title":"A comparison of sustained-release bupropion and placebo for smokeless tobacco cessation","volume":"26","author":"Glover","year":"2002","journal-title":"American Journal of Health Behavior"},{"issue":"4","key":"10.1002\/14651858.CD000031.pub6-BIB0415|cit415","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/1055049029008811","article-title":"Naturalistic, self-assignment comparative trial of bupropion SR, a nicotine patch, or both for smoking cessation treatment in primary care","volume":"11","author":"Gold","year":"2002","journal-title":"American Journal of Addiction"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0416|cit416","unstructured":"Grandi S Shimony A Eisenberg MJ The efficacy and safety of bupropion started in-hospital for smoking cessation in patients with cardiovascular disease: a systematic review and meta-analysis Circulation 2011 124 21 Suppl 1"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0417|cit417","doi-asserted-by":"crossref","unstructured":"Grassi MC Enea D Ferketich AK Lu B Nencini P A smoking ban in public places increases the efficacy of bupropion and counseling on cessation outcomes at 1 year Nicotine & Tobacco Research 2009 11 9 1114 21","DOI":"10.1093\/ntr\/ntp110"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0418|cit418","doi-asserted-by":"crossref","unstructured":"Hall SM Humfleet GL Mu\u00f1oz RF Reus VI Robbins JA Prochaska JJ Extended treatment of older cigarette smokers Addiction 2009 104 6 1043 52","DOI":"10.1111\/j.1360-0443.2009.02548.x"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0419|cit419","doi-asserted-by":"crossref","unstructured":"Hall SM Humfleet GL Munoz RF Reus VI Prochaska JJ Robbins JA Using extended cognitive behavioral treatment and medication to treat dependent smokers American Journal of Public Health 2011 101 12 2349 56","DOI":"10.2105\/AJPH.2010.300084"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0420|cit420","doi-asserted-by":"crossref","unstructured":"Prochaska JJ Hall SM Humfleet G Munoz RF Reus V Gorecki J Physical activity as a strategy for maintaining tobacco abstinence: a randomized trial Preventive Medicine 2008 47 2 215 20","DOI":"10.1016\/j.ypmed.2008.05.006"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0421|cit421","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.amjmed.2003.07.018","article-title":"Effects of sustained-release bupropion among persons interested in reducing but not quitting smoking","volume":"116","author":"Hatsukami","year":"2004","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0422|cit422","unstructured":"Rennard S Hatsukami D Malcolm RE Patel MK Jamerson BD Dozier G Zyban (bupropion HCL SR) vs placebo as an aid to smoking reduction among smokers unwilling and unable to quit smoking (PO4 77) Society for Research on Nicotine and Tobacco 7th Annual Meeting; 2001 March 23; Seattle (WA) 2001 117"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0423|cit423","unstructured":"Hawk LW Mahoney MC Ashare RL Rhodes JD Oliver JA Cummings KM Preliminary evidence of extinction of smoking behavior with bupropion (PA9-4) Society for Research on Nicotine and Tobacco 14th Annual Meeting; 2008 Feb 26 - Mar 1; Portland (OR) 2008"},{"issue":"11","key":"10.1002\/14651858.CD000031.pub6-BIB0424|cit424","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/ntr\/ntu347","article-title":"Does extended pre quit bupropion aid in extinguishing smoking behavior?","volume":"17","author":"Ashare","year":"2015","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0425|cit425","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4065\/80.8.1022","article-title":"Effects of biochemically confirmed smoking cessation on white blood cell count","volume":"80","author":"Abel","year":"2005","journal-title":"Mayo Clinical Proceedings"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0426|cit426","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1525-1497.2004.30423.x","article-title":"Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression","volume":"19","author":"Cox","year":"2004","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0427|cit427","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0149-2918(02)85130-X","article-title":"The effect of bupropion sustained-release on cigarette craving after smoking cessation","volume":"24","author":"Durcan","year":"2002","journal-title":"Clinical Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD000031.pub6-BIB0428|cit428","doi-asserted-by":"crossref","first-page":"456","DOI":"10.5993\/AJHB.28.5.8","article-title":"Bupropion SR for relapse prevention: a \"slips-allowed\" analysis","volume":"28","author":"Durcan","year":"2004","journal-title":"American Journal of Health Behavior"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0429|cit429","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0749-3797(02)00419-1","article-title":"Effects of gender on relapse prevention in smokers treated with bupropion SR","volume":"22","author":"Gonzales","year":"2002","journal-title":"American Journal of Preventive Medicine"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0430|cit430","doi-asserted-by":"crossref","first-page":"423","DOI":"10.7326\/0003-4819-135-6-200109180-00011","article-title":"Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. A randomized, controlled trial","volume":"135","author":"Hays","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD000031.pub6-BIB0431|cit431","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0306-4603(01)00188-5","article-title":"Bupropion for pharmacologic relapse prevention to smoking - predictors of outcome","volume":"27","author":"Hurt","year":"2002","journal-title":"Addictive Behaviors"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0432|cit432","unstructured":"Rigotti N Thorndike AN Durcan MJ White JD Johnston AJ Niaura R Attenuation of post-cessation weight gain in smokers taking bupropion: the effect of gender Abstract Book. Society for Research on Nicotine and Tobacco 6th Annual Meeting; 2000 Feb 18-20; Arlington (VA) 2000"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0433|cit433","doi-asserted-by":"crossref","unstructured":"Hays JT Hurt RD Decker PA Croghan IT Offord KP Patten CA A randomized, controlled trial of bupropion sustained-release for preventing tobacco relapse in recovering alcoholics Nicotine & Tobacco Research 2009 11 7 859 67","DOI":"10.1093\/ntr\/ntp077"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0434|cit434","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1037\/0022-006X.67.4.547","article-title":"Antidepressant pharmacotherapy helps some cigarette smokers more than others","volume":"67","author":"Hitsman","year":"1999","journal-title":"Journal of Consulting and Clinical Psychiatry"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0435|cit435","unstructured":"Hitsman B Spring B Borrelli B Niaura R Papandonatos G Adherence to medication versus behavioral therapy as predictors of smoking cessation in combined treatment involving fluoxetine [abstract] Society for Research on Nicotine and Tobacco Annual Conference; 2000 Feb 18-20; Arlington (VA) 2000"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0436|cit436","unstructured":"Houtsmuller EJ Stitzer ML Selegiline effects on smoking and abstinence [abstract] CPDD Annual Meeting; 1998 June 12-17; Scottsdale (AZ) 1998"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0437|cit437","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00213-002-1152-9","article-title":"Effects of selegiline (l-deprenyl) during smoking and short-term abstinence","volume":"163","author":"Houtsmuller","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0438|cit438","unstructured":"Hurt RD Croghan GA Sloan JA Krook JE Silberstein PT Bupropion for relapse prevention after nicotine patch therapy [PA 5B abstract ] Society for Research on Nicotine and Tobacco 7th Annual Meeting; 2001 March 23; Seattle (WA) 2001 32"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0439|cit439","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1200\/JCO.2003.08.160","article-title":"Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking","volume":"21","author":"Hurt","year":"2003","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0440|cit440","doi-asserted-by":"crossref","unstructured":"Hussain S Zawertailo L Busto U Zack M Farvolden P Selby P The impact of chronic bupropion on plasma cotinine and on the subjective effects of ad lib smoking: a randomized controlled trial in unmotivated smokers Addictive Behaviors 2010 35 2 164 7","DOI":"10.1016\/j.addbeh.2009.09.004"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000031.pub6-BIB0441|cit441","first-page":"S130","article-title":"The combination of sertraline with buspirone for smoking cessation process - the effectiveness and adverse events","volume":"180","author":"Ionescu","year":"2008","journal-title":"Toxicology Letters"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000031.pub6-BIB0442|cit442","first-page":"76A","article-title":"Type a\/type b alcoholism predicts differential response to topiramate in a smoking cessation trial in dually-diagnosed men","volume":"39","author":"Isgro","year":"2015","journal-title":"Alcoholism: Clinical and Experimental Research"},{"issue":"6","key":"10.1002\/14651858.CD000031.pub6-BIB0443|cit443","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/00006842-197111000-00007","article-title":"Interaction of personality and treatment conditions associated with success in a smoking control program","volume":"33","author":"Jacobs","year":"1971","journal-title":"Psychosomatic Medicine"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0444|cit444","unstructured":"Kalman D Engler P Monti P Preliminary findings from a pilot treatment study of smokers in early alcohol recovery (POS1-072) Society for Research on Nicotine and Tobacco 10th Annual Meeting; 2004 February 18-21, Phoenix (AZ) 2004"},{"issue":"60","key":"10.1002\/14651858.CD000031.pub6-BIB0445|cit445","first-page":"4601","article-title":"Comparison of efficacy of varenicline and nortriptyline - short-term smoking cessation in outpatient setting","volume":"48","author":"Khunrong","year":"2016","journal-title":"European Respiratory Journal"},{"issue":"2","key":"10.1002\/14651858.CD000031.pub6-BIB0446|cit446","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1037\/0022-006X.74.2.286","article-title":"Extended treatment with bupropion SR for cigarette smoking cessation","volume":"74","author":"Killen","year":"2006","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0447|cit447","doi-asserted-by":"crossref","unstructured":"Sarginson JE Killen JD Lazzeroni LC Fortmann SP Ryan HS Schatzberg AF Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5-A3-B4) predict severity of nicotine addiction and response to smoking cessation therapy American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 2011 156 3 275 84","DOI":"10.1002\/ajmg.b.31155"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0448|cit448","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/1471-2458-7-332","article-title":"Efficacy of confrontational counselling for smoking cessation in smokers with previously undiagnosed mild to moderate airflow limitation: study protocol of a randomized controlled trial","volume":"7","author":"Kotz","year":"2007","journal-title":"BMC Public Health"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0449|cit449","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1183\/09031936.00116308","article-title":"Efficacy of confronting smokers with airflow limitation for smoking cessation","volume":"33","author":"Kotz","year":"2009","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0450|cit450","doi-asserted-by":"crossref","unstructured":"Kras M Stough C Scholey A Kure C Camfield D Hypericum perforatum, nicotine patches and combination hypericum perforatum\/nicotine patches for smoking cessation European Neuropsychopharmacology 2010 20 S608 9","DOI":"10.1016\/S0924-977X(10)70930-5"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0451|cit451","unstructured":"Lawvere S Mahoney MC Cummings KM Hyland AJ St John's Wort for smoking cessation: twelve months post cessation Society for Research on Nicotine and Tobacco 11th Annual Meeting; 2005 March 20-23; Prague, Czech Republic 2005"},{"issue":"3","key":"10.1002\/14651858.CD000031.pub6-BIB0452|cit452","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ctim.2006.01.007","article-title":"A Phase II study of St. John's Wort for smoking cessation","volume":"14","author":"Lawvere","year":"2006","journal-title":"Complementary Therapies in Medicine"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0453|cit453","unstructured":"Li J Zhang T Wang B Li X An efficacy analysis of bupropion for smoking cessation in schizophrenia Zhongguo Xinyao Yu Linchuang Zazhi [Chinese Journal of New Drugs and Clinical Remedies] 2009 28 3 231 4"},{"issue":"4","key":"10.1002\/14651858.CD000031.pub6-BIB0454|cit454","first-page":"384","article-title":"Comparative study of acupoint catgut embedding and bupropion hydrochloride sustained-release tablets for tobacco dependence","volume":"39","author":"Li","year":"2019","journal-title":"Chinese Acupuncture & Moxibustion"},{"issue":"6","key":"10.1002\/14651858.CD000031.pub6-BIB0455|cit455","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1016\/j.ajog.2003.10.260","article-title":"Bupropion SR for smoking cessation in pregnancy: a pilot study [abstract]","volume":"189","author":"Miller","year":"2003","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"7","key":"10.1002\/14651858.CD000031.pub6-BIB0456|cit456","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.4088\/JCP.v68n0718","article-title":"A randomized, placebo-controlled clinical trial of bupropion for the prevention of smoking in children and adolescents with attention-deficit\/hyperactivity disorder","volume":"68","author":"Monuteaux","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD000031.pub6-BIB0457|cit457","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/10550490802138814","article-title":"Preliminary study of buprenorphine and bupropion for opioid-dependent smokers","volume":"17","author":"Mooney","year":"2008","journal-title":"American Journal on Addictions"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0458|cit458","unstructured":"Sofuoglu M Mooney M Gonzalez G Gonsai K Poling J Kosten T Buprenorphine and bupropion combination for opioid-dependent smokers 68th Annual Scientific Meeting of the College on Problems of Drug Dependence; 2006 June 17-22; Scottsdale (AZ) 2006"},{"issue":"4","key":"10.1002\/14651858.CD000031.pub6-BIB0459|cit459","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/cpt.402","article-title":"Bupropion and naltrexone for smoking cessation: a double-blind randomized placebo-controlled clinical trial","volume":"100","author":"Mooney","year":"2016","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0460|cit460","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/clpt.1990.62","article-title":"Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers","volume":"47","author":"Naranjo","year":"1990","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0461|cit461","unstructured":"S0002 - a program to quit smoking with or without bupropion in treating patients with stage I or II non-small cell lung cancer who have undergone surgery clinicaltrials.gov\/show\/NCT00032084"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0462|cit462","unstructured":"Pilot study of bupropion for smoking cessation in postpartum non-breastfeeding women clinicaltrials.gov\/show\/NCT00119210"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0463|cit463","unstructured":"The effects of memantine and bupropion on acute, reinforcing, and conditioned effects of cigarettes - 1 clinicaltrials.gov\/show\/NCT00136747"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0464|cit464","unstructured":"Effect of memantine versus bupropion on smoking relapse in nicotine-dependent individuals - 3 clinicaltrials.gov\/show\/NCT00136786"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0465|cit465","unstructured":"Effectiveness of various smoking cessation therapies in reducing smoking in adolescents - 1 clinicaltrials.gov\/show\/NCT00158171"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0466|cit466","unstructured":"Efficacy and safety of bupropion for treatment of adolescent smoking clinicaltrials.gov\/ct2\/show\/NCT00248118"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0467|cit467","unstructured":"Smoking relapse prevention in schizophrenia clinicaltrials.gov\/show\/NCT00320697"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0468|cit468","unstructured":"Testing a full substitution therapy approach as treatment of tobacco dependence clinicaltrials.gov\/ct2\/show\/NCT00390923"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0469|cit469","unstructured":"Randomized trial of ultrashort psychotherapy vs sustained-release bupropion for smoking cessation clinicaltrials.gov\/show\/NCT00484692"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0470|cit470","unstructured":"The effect of varenicline (Chantix) and bupropion (Zyban) on smoking lapse behavior clinicaltrials.gov\/show\/nct00580853"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0471|cit471","unstructured":"Randomized trial assessing the effectiveness of a pharmacist-delivered program for smoking cessation clinicaltrials.gov\/show\/NCT00670904"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0472|cit472","unstructured":"Bupropion for ADHD in adolescents with substance use disorder clinicaltrials.gov\/ct2\/show\/NCT00936299"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0473|cit473","unstructured":"Comparison of conservative and aggressive smoking cessation treatment strategies in a vascular surgery office practice clinicaltrials.gov\/show\/NCT01850589"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0474|cit474","unstructured":"Smoking cessation for people living with HIV\/AIDS clinicaltrials.gov\/show\/nct01965405"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0475|cit475","unstructured":"Naltrexone and bupropion combination on obese, smoking patients with schizophrenia clinicaltrials.gov\/show\/NCT02736474"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0476|cit476","unstructured":"AXS-05 phase II trial on smoking behavior clinicaltrials.gov\/show\/NCT03471767"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0477|cit477","unstructured":"Bupropion and cigarette-related cues in smokers clinicaltrials.gov\/show\/nct03920319"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0478|cit478","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1192\/bjp.177.1.87-a","article-title":"Nicotine reduction: effectiveness of bupropion","volume":"177","author":"Neumann","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0479|cit479","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1378\/chest.121.4.1378","article-title":"Nicotine reduction and bupropion","volume":"121","author":"Neumann","year":"2002","journal-title":"Chest"},{"issue":"11","key":"10.1002\/14651858.CD000031.pub6-BIB0480|cit480","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1592\/phco.24.16.1524.50953","article-title":"Bupropion may support psychosocial treatment of nicotine-dependent adolescents: preliminary results","volume":"24","author":"Niederhofer","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0481|cit481","unstructured":"Olmstead R Kelly J Chin C Iwamoto-Schaap PN Madsen DC Huerta L Combined bupropion and mecamylamine treatment for smoking cessation: a pilot trial Society for Research on Nicotine and Tobacco Fifth Annual Meeting; 1999 March 5-7; San Diego (CA) 1999"},{"issue":"2","key":"10.1002\/14651858.CD000031.pub6-BIB0482|cit482","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1345\/aph.1G324","article-title":"Outcomes of bupropion therapy for smoking cessation during routine clinical use","volume":"40","author":"Paluck","year":"2996","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0483|cit483","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0306-4530(91)90008-H","article-title":"Effects of fluoxetine on weight gain and food intake in smokers who reduce nicotine intake","volume":"16","author":"Pomerleau","year":"1991","journal-title":"Psychoneuroendocrinology"},{"issue":"8-B","key":"10.1002\/14651858.CD000031.pub6-BIB0484|cit484","first-page":"4301","article-title":"Adherence to pharmacological smoking cessation treatment among weight-concerned women","volume":"65","author":"Raynor","year":"2005","journal-title":"Dissertation Abstracts International: Section B: The Sciences and Engineering"},{"issue":"2","key":"10.1002\/14651858.CD000031.pub6-BIB0485|cit485","first-page":"89","article-title":"Buspirone effect on tobacco withdrawal symptoms: a pilot study","volume":"4","author":"Robinson","year":"1991","journal-title":"Journal of the American Board of Family Practice"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0486|cit486","volume-title":"Effects of bupropion during smoking abstinence on Loreta-assessed frontal lobe activity [PhD thesis]","author":"Ruehle","year":"2021"},{"issue":"S63","key":"10.1002\/14651858.CD000031.pub6-BIB0487|cit487","doi-asserted-by":"publisher","first-page":"PA2237","DOI":"10.1183\/13993003.congress-2019.PA2237","article-title":"Use of a mobile app to give up smoking. Results from a clinical trial","volume":"54","author":"Sanchez","year":"2019","journal-title":"European Respiratory Journal"},{"issue":"S1","key":"10.1002\/14651858.CD000031.pub6-BIB0488|cit488","first-page":"902","article-title":"Characteristics of individuals that complete treatment v. discontinue among criminal justice smokers","volume":"6","author":"Schiavon","year":"2018","journal-title":"Tobacco Induced Diseases"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0489|cit489","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00004714-198712000-00009","article-title":"Do serotonin uptake inhibitors decrease smoking? Observations in a group of heavy drinkers","volume":"7","author":"Sellers","year":"1987","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD000031.pub6-BIB0490|cit490","doi-asserted-by":"crossref","first-page":"550","DOI":"10.7205\/MILMED.173.6.550","article-title":"Comparing the tolerability and effectiveness of two treatment regimens in a smoking clinic","volume":"173","author":"Sherman","year":"2008","journal-title":"Military Medicine"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0491|cit491","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s002130050022","article-title":"The effect of bupropion on nicotine craving and withdrawal","volume":"148","author":"Shiffman","year":"2000","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD000031.pub6-BIB0492|cit492","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.03.010","article-title":"Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence","volume":"96","author":"Shoptaw","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD000031.pub6-BIB0493|cit493","first-page":"A223","article-title":"The effectiveness of nortriptyline plus brief motivation counseling for the treatment of smoking cessation in Thai active smokers [Abstract]","volume":"12","author":"Sittipunt","year":"2007","journal-title":"Respirology"},{"issue":"6","key":"10.1002\/14651858.CD000031.pub6-BIB0494|cit494","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/ajcn\/62.6.1181","article-title":"Efficacies of dexfenfluramine and fluoxetine in preventing weight gain after smoking cessation","volume":"62","author":"Spring","year":"1995","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0495|cit495","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1037\/1064-1297.1.1-4.188","article-title":"Impairment of memory by fluoxetine in smokers","volume":"1","author":"Stein","year":"1993","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"7","key":"10.1002\/14651858.CD000031.pub6-BIB0496|cit496","doi-asserted-by":"crossref","first-page":"447","DOI":"10.7326\/0003-4819-150-7-200904070-00004","article-title":"Triple-combination pharmacotherapy for medically ill smokers: a randomized trial","volume":"150","author":"Steinberg","year":"2009","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0497|cit497","unstructured":"Strayer SM Flusche A Hodge J Martindale JR Effectiveness trial of Zyban for smoking cessation in the outpatient setting (POS1-044) Abstract Book. Society for Research on Nicotine and Tobacco 10th Annual Meeting; 2004 February 18-21; Phoenix (AZ) 2004 45"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0498|cit498","unstructured":"Efficacy and safety of Vernonia cinerea for smoking cessation trialsearch.who.int\/Trial2.aspx?TrialID=TCTR20190506002"},{"issue":"3","key":"10.1002\/14651858.CD000031.pub6-BIB0499|cit499","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/ntr\/ntn032","article-title":"Intention to quit moderates the effect of bupropion on smoking urge","volume":"11","author":"Tidey","year":"2009","journal-title":"Nicotine & Tobacco Research"},{"issue":"3","key":"10.1002\/14651858.CD000031.pub6-BIB0500|cit500","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.drugalcdep.2008.05.013","article-title":"Comparison of expired carbon monoxide and plasma cotinine as markers of cigarette abstinence","volume":"98","author":"Jatlow","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"issue":"12","key":"10.1002\/14651858.CD000031.pub6-BIB0501|cit501","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1080\/14622200802443742","article-title":"Risk factors for treatment failure in smokers: relationship to alcohol use and to lifetime history of an alcohol use disorder","volume":"10","author":"Leeman","year":"2008","journal-title":"Nicotine & Tobacco Research"},{"issue":"4","key":"10.1002\/14651858.CD000031.pub6-BIB0502|cit502","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1037\/0893-164X.21.4.534","article-title":"Comparing gain- and loss-framed messages for smoking cessation with sustained-release bupropion: a randomized controlled trial","volume":"21","author":"Toll","year":"2007","journal-title":"Psychology of Addictive Behaviors"},{"issue":"1","key":"10.1002\/14651858.CD000031.pub6-BIB0503|cit503","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/14622200701767803","article-title":"Message framing for smoking cessation: the interaction of risk perceptions and gender","volume":"10","author":"Toll","year":"2008","journal-title":"Nicotine & Tobacco Research"},{"issue":"4","key":"10.1002\/14651858.CD000031.pub6-BIB0504|cit504","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1176\/appi.ajp.158.4.635","article-title":"Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia","volume":"158","author":"Weiner","year":"2001","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000031.pub6-BIB0505|cit505","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cct.2011.09.018","article-title":"Design considerations for a study to evaluate the impact of smoking cessation treatment on stimulant use outcomes in stimulant-dependent individuals","volume":"33","author":"Winhusen","year":"2012","journal-title":"Contemporary Clinical Trials"},{"issue":"12","key":"10.1002\/14651858.CD000031.pub6-BIB0506|cit506","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1111\/j.1360-0443.2008.02348.x","article-title":"A randomized trial of short psychotherapy versus sustained-release bupropion for smoking cessation","volume":"103","author":"Zernig","year":"2008","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0507|cit507","unstructured":"A multicentre, randomised, double-blind, placebo controlled study to evaluate the efficacy and tolerability of bupropion hydrochloride (SR) sustained release (2 x 150mg per day) versus placebo as an aid to smoking cessation in smokers with at least one cardiovascular (CV) risk factor gsk-studyregister.com\/en\/trial-details\/?id=ZYB%2030011"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0508|cit508","unstructured":"High dose bupropion for smoking cessation clinicaltrials.gov\/ct2\/show\/NCT03326128"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0509|cit509","unstructured":"Smoking cessation interventions for people living with HIV in Nairobi, Kenya clinicaltrials.gov\/ct2\/show\/NCT03342027"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0510|cit510","unstructured":"Nicotine replacement therapy, counseling, varenicline, and bupropion for smoking cessation, the PISCES I trial clinicaltrials.gov\/show\/NCT04604509"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0511|cit511","unstructured":"The effects of combination zonisamide and bupropion on switching to an electronic cigarette clinicaltrials.gov\/show\/NCT05205811"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0512|cit512","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2165\/00003495-200262002-00005","article-title":"Tolerability and safety of sustained-release bupropion in the management of smoking cessation","volume":"62","year":"2002","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0513|cit513","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2165\/00023210-200013040-00004","article-title":"Non-nicotine pharmacotherapy for smoking cessation","volume":"13","author":"Benowitz","year":"2000","journal-title":"CNS Drugs"},{"issue":"5","key":"10.1002\/14651858.CD000031.pub6-BIB0514|cit514","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009329.pub2","article-title":"Pharmacological interventions for smoking cessation: an overview and network meta-analysis","author":"Cahill","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0515|cit515","first-page":"1457","article-title":"Quitting smoking among adults\u2014United States, 2000\u20132015","volume":"52","author":"Centers for Disease Control and Prevention","year":"2017","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"3","key":"10.1002\/14651858.CD000031.pub6-BIB0516|cit516","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010078.pub3","article-title":"Pharmacological interventions for promoting smoking cessation during pregnancy","author":"Claire","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0517|cit517","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00213-003-1445-7","article-title":"Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat","volume":"168","author":"Cryan","year":"2003","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD000031.pub6-BIB0518|cit518","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004306.pub4","article-title":"Interventions for smokeless tobacco use cessation","author":"Ebbert","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD000031.pub6-BIB0519|cit519","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/j.1360-0443.2007.01822.x","article-title":"The impact of pharmaceutical company funding on results of randomized trials of nicotine replacement therapy for smoking cessation: a meta-analysis","volume":"102","author":"Etter","year":"2007","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0520|cit520","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1176\/appi.ps.202000032","article-title":"Efficacy and safety of pharmacotherapeutic smoking cessation aids in schizophrenia spectrum disorders: subgroup analysis of EAGLES","volume":"72","author":"Evins","year":"2021","journal-title":"Psychiatric Services"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0521|cit521","volume-title":"Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. AHRQ publication No. 00-0032","author":"Fiore","year":"2008"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0522|cit522","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0022-3565(24)37928-5","article-title":"Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine","volume":"288","author":"Fryer","year":"1999","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"10292","key":"10.1002\/14651858.CD000031.pub6-BIB0523|cit523","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1016\/S0140-6736(21)01169-7","article-title":"Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990\u20132019: a systematic analysis from the Global Burden of Disease Study 2019","volume":"397","author":"Global Burden of Disease 2019 Tobacco Collaborators","year":"2021","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0524|cit524","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime)"},{"issue":"5","key":"10.1002\/14651858.CD000031.pub6-BIB0525|cit525","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000146.pub5","article-title":"Nicotine replacement therapy versus control for smoking cessation","author":"Hartmann-Boyce","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0526|cit526","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analysis","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0527|cit527","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0528|cit528","doi-asserted-by":"crossref","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (updated July 2019). The Cochrane Collaboration, 2019 Available from www.training.cochrane.org\/handbook 2019","DOI":"10.1002\/9781119536604"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0529|cit529","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/14622200500185298","article-title":"Nortriptyline for smoking cessation: a review","volume":"7","author":"Hughes","year":"2005","journal-title":"Nicotine & Tobacco Research"},{"issue":"3","key":"10.1002\/14651858.CD000031.pub6-BIB0530|cit530","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14622200701188919","article-title":"Effects of abstinence from tobacco: valid symptoms and time course","volume":"9","author":"Hughes","year":"2007","journal-title":"Nicotine & Tobacco Research"},{"issue":"2","key":"10.1002\/14651858.CD000031.pub6-BIB0531|cit531","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/BF03391651","article-title":"Avoidable deaths from smoking: a global perspective","volume":"33","author":"Jha","year":"2011","journal-title":"Public Health Reviews"},{"issue":"3","key":"10.1002\/14651858.CD000031.pub6-BIB0532|cit532","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/ntr\/nty225","article-title":"Study characteristics influence the efficacy of substance abuse treatments: a meta-analysis of medications for smoking cessation","volume":"22","author":"Klemperer","year":"2020","journal-title":"Nicotine and Tobacco Research"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0533|cit533","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1592\/phco.21.20.1530.34477","article-title":"Effect of nonnicotine pharmacotherapy on smoking behavior","volume":"21","author":"Kotlyar","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0534|cit534","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0376-8716(02)00067-4","article-title":"Mediating mechanisms for the impact of bupropion in smoking cessation treatment","volume":"67","author":"Lerman","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1002\/14651858.CD000031.pub6-BIB0535|cit535","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuro.2006.05.019","article-title":"Monoamine oxidase and tobacco dependence","volume":"28","author":"Lewis","year":"2007","journal-title":"NeuroToxicology"},{"issue":"3","key":"10.1002\/14651858.CD000031.pub6-BIB0536|cit536","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015226","article-title":"Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses","author":"Lindson","year":"2022","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD000031.pub6-BIB0537|cit537","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005231.pub3","article-title":"Interventions to reduce harm from continued tobacco use","author":"Lindson-Hawley","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD000031.pub6-BIB0538|cit538","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003999.pub6","article-title":"Relapse prevention interventions for smoking cessation","author":"Livingstone-Banks","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD000031.pub6-BIB0539|cit539","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006103.pub8","article-title":"Nicotine receptor partial agonists for smoking cessation","author":"Livingstone-Banks","year":"2023","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD000031.pub6-BIB0540|cit540","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/add.14043","article-title":"A man before his time: Russell's insights into nicotine, smoking, treatment and curbing the smoking problem","volume":"113","author":"McNeill","year":"2017","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0541|cit541","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.rmed.2005.05.016","article-title":"Non-nicotine pharmacotherapies for smoking cessation","volume":"99","author":"McRobbie","year":"2005","journal-title":"Respiratory Medicine"},{"issue":"6","key":"10.1002\/14651858.CD000031.pub6-BIB0542|cit542","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3109\/07853890.2012.705016","article-title":"Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: a systematic review and multiple treatment meta-analysis","volume":"44","author":"Mills","year":"2012","journal-title":"Annals of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD000031.pub6-BIB0543|cit543","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0544|cit544","unstructured":"National Institute for Health and Clinical Excellence Tobacco: preventing uptake, promoting quitting and treating dependence. NICE guideline 209; November 2021 Available at: www.nice.org.uk\/guidance\/ng209"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0545|cit545","volume-title":"Interventions for Tobacco Cessation in Adults, Including Pregnant Women: An Evidence Update for the U.S. Preventive Services Task Force","author":"Patnode","year":"2021"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0546|cit546","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013 Available from gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html"},{"issue":"3","key":"10.1002\/14651858.CD000031.pub6-BIB0547|cit547","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013522.pub2","article-title":"Smoking cessation for improving mental health","author":"Taylor","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0548|cit548","unstructured":"Theodoulou A Chepkin SC Ye W Fanshawe TR Bullen C Hartmann-Boyce J Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD000031.pub6-BIB0549|cit549","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/add.15675","article-title":"Comparative clinical effectiveness and safety of tobacco cessation pharmacotherapies and electronic cigarettes: a systematic review and network meta-analysis of randomized controlled trials","volume":"117","author":"Thomas","year":"2022","journal-title":"Addiction"},{"issue":"5","key":"10.1002\/14651858.CD000031.pub6-BIB0550|cit550","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1192\/bjp.bp.109.066019","article-title":"Efficacy and safety of bupropion for smoking cessation and reduction in schizophrenia: systematic review and meta-analysis","volume":"196","author":"Tsoi","year":"2010","journal-title":"British Journal of Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD000031.pub6-BIB0551|cit551","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006102.pub2","article-title":"Smoking cessation interventions for smokers with current or past depression","author":"Van der Meer","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD000031.pub6-BIB0552|cit552","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1360-0443.2004.00995.x","article-title":"Outcome criteria in smoking cessation trials: proposal for a common standard","volume":"100","author":"West","year":"2005","journal-title":"Addiction"},{"issue":"3","key":"10.1002\/14651858.CD000031.pub6-BIB0553|cit553","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00213-007-1041-3","article-title":"Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt","volume":"197","author":"West","year":"2008","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1002\/14651858.CD000031.pub6-BIB0554|cit554","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/add.14208","article-title":"Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLES","volume":"113","author":"West","year":"2018","journal-title":"Addiction"},{"issue":"5","key":"10.1002\/14651858.CD000031.pub6-BIB0555|cit555","first-page":"e1","article-title":"Meta-analysis of suicidality in placebo-controlled clinical trials of adults taking bupropion","volume":"12","author":"Wightman","year":"2010","journal-title":"Primary Care Companion to the Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0556|cit556","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1136\/pgmj.2005.032433","article-title":"Pragmatic, observational study of bupropion treatment for smoking cessation in general practice","volume":"81","author":"Wilkes","year":"2005","journal-title":"Postgraduate Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD000031.pub6-BIB0557|cit557","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000031.pub5","article-title":"Antidepressants for smoking cessation","author":"Howes","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000031.pub6-BIB0558|cit558","first-page":"197","article-title":"Non-nicotine pharmacotherapies for smoking cessation","volume":"6","author":"Hughes","year":"1994","journal-title":"Journal of Drug Development"},{"issue":"4","key":"10.1002\/14651858.CD000031.pub6-BIB0559|cit559","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002849","article-title":"Anxiolytics and antidepressants for smoking cessation","author":"Hughes","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD000031.pub6-BIB0560|cit560","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000031.pub4","article-title":"Antidepressants for smoking cessation","author":"Hughes","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T13:36:11Z","timestamp":1752586571000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD000031.pub6"}},"subtitle":[],"editor":[{"name":"Cochrane Tobacco Addiction Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,5,24]]},"references-count":560,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000031.pub6","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,24]]}}}